"phase_id","region","country","location","sampleType","startDate","endDate","midpointDate","testTime","testName","citationID","nSeropositives","nSamples","sensitivityMean","sensitivityL","sensitivityH","includedTable","notes","timeKnown","antigenTarget","antibodyTarget","technique","design","RBD","S","N","LFA","Indirect","Direct","Neutralization","validationGroup","predictedPos","predictedPosL","predictedPosH","sensitivityMeanPred","sensitivityMedianPred","sensitivityLPred","sensitivityHPred"
"--","Oceania","Australia","{ Victoria }","hospitalized + non-hospitalized patients","--","--","--",4.5,"Abbott Architect IgG","n-240",11,11,100,71.51,100,"Yes","table 1",TRUE,"N","IgG","CMIA","indirect",FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,69,9,6,11,82.2498980609767,82.8619621915159,68.5218098279763,92.2704579138207
"--","Europe","Germany","Dresden","hospitalized + non-hospitalized patients","*August 2020","*October 2020","*September 2020",5,"Abbott Architect IgG","n-133",64,109,58.72,48.88,68.06,"Yes","table 2",TRUE,"N","IgG","CMIA","indirect",FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,69,69,24,100,61.4036816461439,63.4423847343469,22.7190943079197,90.5478589388435
"--","North America","USA","{ San Francisco }","non-hospitalized patients","--","--","--",5,"Abbott Architect IgG","n-132",81,144,56.2,48.2,64.7,"Not yet","supplementary table 8",TRUE,"N","IgG","CMIA","indirect",FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,69,100,80,117,68.9180883311382,69.1008945931681,57.9572542734215,78.8236484488577
"3","South Asia","India","National","representative","--","--","12/27/2020",5,"Abbott Architect IgG","n-96",26,74,35.14,24.39,47.11,"Yes","supplementary table (page 8 of appendix)",TRUE,"N","IgG","CMIA","indirect",FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,69,25,15,37,34.4442603244107,34.2736169084345,23.9392556711981,46.152114250558
"--","Oceania","Australia","{ Victoria }","hospitalized + non-hospitalized patients","--","--","--",6,"Abbott Architect IgG","n-240",30,44,68.18,52.42,81.39,"Yes","table 1",TRUE,"N","IgG","CMIA","indirect",FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,69,33,22,41,74.3807051915654,75.2415677276999,54.4276904935885,89.3585441131195
"--","Europe","Germany","{ Saarland }","non-hospitalized patients","--","*October 2020","*October 2020",6,"Abbott Architect IgG","n-289",15,30,50,31.3,68.7,"Yes","figure 2g",TRUE,"N","IgG","CMIA","indirect",FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,69,17,4,28,55.0975488519908,55.9994550493855,17.5485463983938,88.6640453516478
"--","North America","USA","{ San Francisco }","non-hospitalized patients","--","--","--",7,"Abbott Architect IgG","n-132",35,107,32.8,24.2,42.3,"Not yet","supplementary table 8",TRUE,"N","IgG","CMIA","indirect",FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,69,58,37,79,54.4196044830444,54.5134589315814,36.5650731998495,71.9864828953537
"3","South Asia","India","National","representative","--","--","12/27/2020",7,"Abbott Architect IgG","n-96",6,23,26.09,10.23,48.41,"N","supplementary table (page 8 of appendix)",TRUE,"N","IgG","CMIA","indirect",FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,69,5,1,11,22.4352107737353,21.8311457581036,11.841951468649,36.4013174183219
"--","Europe","Germany","Dresden","hospitalized + non-hospitalized patients","*January 2021","*March 2021","*February 2021",10,"Abbott Architect IgG","n-133",26,109,23.85,16.21,32.97,"Yes","table 2",TRUE,"N","IgG","CMIA","indirect",FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,69,29,4,81,30.1097343885911,26.4256943073804,4.32757793474055,73.4236515217324
"--","Oceania","New Zealand","{ Southern District Health Board region }","hospitalized + non-hospitalized patients","3/11/2020","4/5/2020","--",10,"Abbott Architect IgG","n-198",10,37,27.03,13.79,44.12,"Yes","",TRUE,"N","IgG","CMIA","indirect",FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,69,10,1,28,30.2269298438368,26.5866363750304,4.5709325702463,72.7236353890406
"1,2","South Asia","India","Tamil Nadu: Chennai","representative","7/17/2020","10/15/2020","8/31/2020",4.5,"Abbott Architect IgG","n-89",10,14,71.43,41.9,91.61,"","appendix table 8 (not yet included in seroreversion paper)",TRUE,"N","IgG","CMIA","indirect",FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,69,11,7,14,74.8210581791603,75.1983279475755,61.6388330885225,85.7773449506164
"--","Europe","Germany","--","hospitalized + non-hospitalized patients","--","--","*2020",6,"Abbott Architect IgG","n-290",101,162,62.35,54.4,69.83,"","table 1",TRUE,"N","IgG","CMIA","indirect",FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,69,127,106,143,77.9689354745684,78.3464937594072,67.2575568065231,86.5491236477473
"--","Europe","Germany","--","hospitalized + non-hospitalized patients","--","--","*2020",8,"Abbott Architect IgG","n-290",41,95,43.16,33.03,53.72,"","table 1",TRUE,"N","IgG","CMIA","indirect",FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,69,63,42,80,65.4037357513888,65.9436067734349,46.2077639421298,81.3521088580561
"--","Europe","Germany","--","hospitalized + non-hospitalized patients","--","--","*2020",10,"Abbott Architect IgG","n-290",22,89,24.72,16.19,35,"","table 1",TRUE,"N","IgG","CMIA","indirect",FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,69,45,21,69,50.8850165294132,50.8411370703726,26.142926391042,75.1634474163218
"--","Europe","Germany","--","hospitalized + non-hospitalized patients","--","--","*2020",12,"Abbott Architect IgG","n-290",18,91,19.78,12.16,29.45,"","table 1",TRUE,"N","IgG","CMIA","indirect",FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,69,33,10,63,37.0411282542758,35.6483347839791,12.5360247269053,68.0358231444206
"--","Europe","Germany","--","hospitalized + non-hospitalized patients","--","--","*2020",14,"Abbott Architect IgG","n-290",5,35,14.29,4.806,30.26,"","table 1",TRUE,"N","IgG","CMIA","indirect",FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,69,8,1,22,25.7134572910616,22.9211567571037,5.49414227516583,60.2467846418606
"3","South Asia","India","National","representative","--","--","12/27/2020",1,"Abbott Architect IgG","n-96",19,38,50,33.38,66.62,"Yes","supplementary table (page 8 of appendix)",TRUE,"N","IgG","CMIA","indirect",FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,68,26,19,33,69.0945556979081,69.367406241036,58.1852594111724,78.3754636511606
"--","Europe","Ireland","{ Dublin }","hospitalized + non-hospitalized patients","3/26/2020","7/10/2020","5/18/2020",1,"Abbott Architect IgG","n-225",149,185,80.54,74.09,85.98,"Yes","table 3",TRUE,"N","IgG","CMIA","indirect",FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,68,158,99,180,82.8449474692533,85.6350095641828,54.0109993453185,96.9420367907158
"--","Oceania","Australia","{ Victoria }","hospitalized + non-hospitalized patients","--","--","--",1,"Abbott Architect IgG","n-240",40,42,95.24,83.84,99.42,"Yes","table 1",TRUE,"N","IgG","CMIA","indirect",FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,68,39,34,42,92.3253031078959,92.5979016437648,87.185787534553,95.9204838525605
"--","North America","USA","{ San Francisco }","non-hospitalized patients","*April 2020","*July 2020","--",1,"Abbott Architect IgG","n-132",158,173,91.4,86.4,94.9,"Not yet","supplementary table 8",TRUE,"N","IgG","CMIA","indirect",FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,68,140,125,153,80.7464198330201,80.8866554625517,74.5917216457729,86.0227021552697
"--","South Asia","India","{ Delhi }","hospitalized + non-hospitalized patients","--","--","12/18/2020",2,"Abbott Architect IgG","n-162",527,673,78.31,75,81.36,"Yes","table 2",TRUE,"N","IgG","CMIA","indirect",FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,68,547,308.975,645,78.3434001811183,81.2385996944324,45.9703516413936,95.7495267319044
"--","Oceania","Australia","{ Sydney }","hospitalized + non-hospitalized patients","*March 2020","*August 2020","--",2,"Abbott Architect IgG","n-215",116,166,69.88,62.29,76.75,"Yes","table 2",TRUE,"N","IgG","CMIA","indirect",FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,68,135,74,160,78.1861991035173,80.9454808125597,45.0371996022349,95.7557434970099
"1","Europe","Italy","Vo'","representative","5/1/2020","5/3/2020","5/2/2020",2,"Abbott Architect IgG","n-108",60,62,96.77,88.83,99.61,"Yes","supplementary table 2",TRUE,"N","IgG","CMIA","indirect",FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,68,50,27,60,78.2978609861848,80.9479179682858,45.8971979125794,95.9065774921073
"--","Oceania","Australia","{ Victoria }","hospitalized + non-hospitalized patients","--","--","--",2,"Abbott Architect IgG","n-240",36,39,92.31,79.13,98.38,"Yes","table 1",TRUE,"N","IgG","CMIA","indirect",FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,68,35,30,39,89.7063424741904,90.0050414246841,83.2913918282369,94.322482933483
"--","North America","USA","{ San Francisco }","non-hospitalized patients","--","--","--",3,"Abbott Architect IgG","n-132",127,163,77.7,70.7,83.7,"Not yet","supplementary table 8",TRUE,"N","IgG","CMIA","indirect",FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,68,112,96,127,68.6597596271724,68.7164070902336,62.1944210452744,74.6955435011795
"--","North America","USA","{ ? }","non-hospitalized patients","--","--","--",3,"Abbott Architect IgG","n-134",29,41,70.73,54.46,83.87,"Yes","figure 1",TRUE,"N","IgG","CMIA","indirect",FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,68,31,14,40,73.0240407228864,75.9361463970655,37.079600852516,94.1223748301229
"3","South Asia","India","National","representative","--","--","12/27/2020",3,"Abbott Architect IgG","n-96",51,96,53.12,42.66,63.39,"Yes","supplementary table (page 8 of appendix)",TRUE,"N","IgG","CMIA","indirect",FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,68,52,38,65,53.9349071260727,54.0037799018244,43.0962832218798,64.1783875923262
"--","Europe","Germany","--","hospitalized + non-hospitalized patients","--","--","*2020",1,"Abbott Architect IgG","n-290",33,39,84.62,69.47,94.14,"","table 1",TRUE,"N","IgG","CMIA","indirect",FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,68,35,30,38,88.6322163102922,88.8302870523397,83.2893120347291,92.8387989332545
"1,2","South Asia","India","Tamil Nadu: Chennai","representative","7/17/2020","10/15/2020","8/31/2020",1.5,"Abbott Architect IgG","n-89",22,24,91.67,73,98.97,"","appendix table 8 (not yet included in seroreversion paper)",TRUE,"N","IgG","CMIA","indirect",FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,68,21,15,24,85.214582842613,86.0898090784083,71.1078848916453,94.4027568451453
"--","Europe","Germany","--","hospitalized + non-hospitalized patients","--","--","*2020",2,"Abbott Architect IgG","n-290",186,194,95.88,92.04,98.2,"","table 1",TRUE,"N","IgG","CMIA","indirect",FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,68,165,149,178,84.9673177634186,85.1477458327101,79.0843387847096,89.8543938339178
"1,2","South Asia","India","Tamil Nadu: Chennai","representative","7/17/2020","10/15/2020","8/31/2020",2.5,"Abbott Architect IgG","n-89",26,29,89.66,72.65,97.81,"","appendix table 8 (not yet included in seroreversion paper)",TRUE,"N","IgG","CMIA","indirect",FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,68,24,17,28,80.7721521222158,81.6596351698883,64.2481081944237,92.3233168850529
"1,2","South Asia","India","Tamil Nadu: Chennai","representative","7/17/2020","10/15/2020","8/31/2020",3.5,"Abbott Architect IgG","n-89",16,22,72.73,49.78,89.27,"","appendix table 8 (not yet included in seroreversion paper)",TRUE,"N","IgG","CMIA","indirect",FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,68,17,11,21,75.3985600664751,76.2215967513153,56.5680148807703,89.5997001208753
"--","Europe","Germany","--","hospitalized + non-hospitalized patients","--","--","*2020",4,"Abbott Architect IgG","n-290",106,123,86.18,78.8,91.74,"","table 1",TRUE,"N","IgG","CMIA","indirect",FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,68,92,79,103,74.7488897817035,74.8423084598296,68.3547632830199,80.5805091604323
"1","Europe","Austria","Ischgl","representative","4/21/2020","4/27/2020","2020-04-24",1,"Abbott Architect IgG","n-109",99,105,94.29,87.98,97.87,NA,"table 2",FALSE,"N","IgG","CMIA","indirect",FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,68,90,55,103,82.8011402105017,85.5371286304464,53.2365157682281,96.9561930442647
"1","Europe","Spain","National","representative","4/27/2020","5/11/2020","2020-05-04",1,"Abbott Architect IgG","n-44",176,195,90.26,85.2,94.03,NA,"table 3",FALSE,"N","IgG","CMIA","indirect",FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,68,167,103,190,82.9661653987562,85.7632173304323,53.0558755424056,96.8977991669047
"1","North America","USA","Davis, Salt Lake, Summit, and Utah counties","representative","5/1/2020","6/30/2020","2020-05-31",1,"Abbott Architect IgG","n-10",25,30,83.33,65.28,94.36,NA,"",FALSE,"N","IgG","CMIA","indirect",FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,68,26,15,30,82.8085046404229,85.7106968535145,53.0293526467584,96.9666780590145
"1","Africa","Ethiopia","14 towns (including Addis Ababa #2)","representative","6/24/2020","7/8/2020","2020-07-01",1,"Abbott Architect IgG","n-98",30,55,54.55,40.55,68.03,NA,"",FALSE,"N","IgG","CMIA","indirect",FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,68,47,28,54,82.8012116289349,85.6329305439341,52.3217589339192,96.8922125747349
"2","South Asia","India","National","representative","8/17/2020","9/22/2020","2020-09-04",1,"Abbott Architect IgG","n-85",38,44,86.36,72.65,94.83,NA,"table 2 (excluded 3 samples for taken within 14 days)",FALSE,"N","IgG","CMIA","indirect",FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,68,38,22,44,82.8150286738342,85.5952025576582,52.2800168028304,96.971164222987
"1","South Asia","India","Kashmir: Srinagar district","representative","10/17/2020","10/20/2020","2020-10-18",1,"Abbott Architect IgG","n-92",100,121,82.64,74.7,88.92,NA,"table 1 (1 - 4 month time interval stated on page 1795)",FALSE,"N","IgG","CMIA","indirect",FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,68,103,64,118,82.7444581845535,85.5032443413254,54.1865421573201,96.9404254421539
"1","South Asia","India","Kashmir (whole region)","representative","10/17/2020","11/4/2020","2020-10-26",2,"Abbott Architect IgG","n-91",140,172,81.4,74.76,86.91,NA,"176 individuals (with 4 seronegatives removed for testing earlier than 14 days)",FALSE,"N","IgG","CMIA","indirect",FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,68,140,76,166,78.2816426620138,81.3793044765885,44.3905414831951,95.8017516940088
"4","South Asia","India","National","representative","6/14/2021","7/6/2021","2021-06-25",2,"Abbott Architect IgG","n-97",464,782,59.34,55.8,62.8,NA,"S1 table",FALSE,"N","IgG","CMIA","indirect",FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,68,633,349,750,78.1154226537515,80.924820837953,44.7774590469326,95.7955315035036
"--","Oceania","Australia","{ Victoria }","hospitalized + non-hospitalized patients","--","--","--",4.5,"Elecsys Anti-SARS-CoV-2 Roche nucleocapsid IgG IgM","n-240",11,11,100,71.51,100,"Yes","table 1",TRUE,"N","IgG IgM IgA","CMIA","sandwich",FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,67,11,9,11,96.93663454749,97.2741027436041,92.8273719807282,99.1220634816675
"--","Europe","Germany","{ Cologne }","hospitalized + non-hospitalized patients","*August 2020","*September 2020","--",5,"Elecsys Anti-SARS-CoV-2 Roche nucleocapsid IgG IgM","n-222",338,363,93.11,90,95.49,"Yes","supplementary table S2",TRUE,"N","IgG IgM IgA","CMIA","sandwich",FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,67,345,278.975,361,93.3496807167231,95.1732297744365,76.9211949961552,99.1475368124076
"--","North America","USA","{ San Francisco }","non-hospitalized patients","--","--","--",5,"Elecsys Anti-SARS-CoV-2 Roche nucleocapsid IgG IgM","n-132",144,158,90.7,85.4,94.6,"Not yet","supplementary table 8",TRUE,"N","IgG IgM IgA","CMIA","sandwich",FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,67,149,138,156,94.0185571518775,94.3415762999662,88.9248713617158,97.3860043069904
"--","Oceania","Australia","{ Victoria }","hospitalized + non-hospitalized patients","--","--","--",6,"Elecsys Anti-SARS-CoV-2 Roche nucleocapsid IgG IgM","n-240",43,44,97.73,87.98,99.94,"Yes","table 1",TRUE,"N","IgG IgM IgA","CMIA","sandwich",FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,67,43,40,44,97.5494036957744,97.9570813971667,93.3232975496616,99.4702218135391
"--","East Asia","Japan","{ ? }","convenience (general population)","9/2/2020","10/26/2020","9/29/2020",6,"Elecsys Anti-SARS-CoV-2 Roche nucleocapsid IgG IgM","n-167",367,376,97.61,95.5,98.9,"Yes","",TRUE,"N","IgG IgM IgA","CMIA","sandwich",FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,67,361,293,375,94.1517147977836,95.9625971901011,78.0800566803827,99.404145827357
"--","Europe","Germany","{ Saarland }","non-hospitalized patients","--","*October 2020","*October 2020",6,"Elecsys Anti-SARS-CoV-2 Roche nucleocapsid IgG IgM","n-289",30,30,100,88.43,100,"Yes","figure 2g",TRUE,"N","IgG IgM IgA","CMIA","sandwich",FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,67,29,23,30,94.1907737827881,95.9310264182119,78.0047937856392,99.3721314834717
"--","North America","USA","{ San Francisco }","non-hospitalized patients","--","--","--",7,"Elecsys Anti-SARS-CoV-2 Roche nucleocapsid IgG IgM","n-132",133,146,91.1,85.7,95.1,"Not yet","supplementary table 8",TRUE,"N","IgG IgM IgA","CMIA","sandwich",FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,67,140,128,145,95.5079269954103,96.0677180735009,89.0667694744011,98.7976709452379
"--","East Asia","South Korea","{ ? }","non-hospitalized patients","--","--","--",8,"Elecsys Anti-SARS-CoV-2 Roche nucleocapsid IgG IgM","n-165",53,58,91.38,81.02,97.14,"Yes","",TRUE,"N","IgG IgM IgA","CMIA","sandwich",FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,67,56,46,58,95.5448213765859,97.2399635903069,81.0171398855309,99.6577569520142
"--","Europe","Sweden","{ Stockholm }","hospitalized + non-hospitalized patients","--","late 2020","--",9,"Elecsys Anti-SARS-CoV-2 Roche nucleocapsid IgG IgM","n-223",31,32,96.88,83.78,99.92,"Yes","tables 2 and 3",TRUE,"N","IgG IgM IgA","CMIA","sandwich",FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,67,31,25,32,96.0065129852018,97.7144027093218,82.2260345847498,99.7639138873263
"--","Europe","Germany","--","hospitalized + non-hospitalized patients","--","--","*2020",6,"Elecsys Anti-SARS-CoV-2 Roche nucleocapsid IgG IgM","n-290",160,162,98.77,95.61,99.85,"","table 1",TRUE,"N","IgG IgM IgA","CMIA","sandwich",FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,67,160,155,162,98.4864763903366,98.6365200774417,96.6065563717041,99.534489964268
"--","Europe","Germany","--","hospitalized + non-hospitalized patients","--","--","*2020",8,"Elecsys Anti-SARS-CoV-2 Roche nucleocapsid IgG IgM","n-290",93,95,97.89,92.6,99.74,"","table 1",TRUE,"N","IgG IgM IgA","CMIA","sandwich",FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,67,94,91,95,98.8569693453134,99.0680578790978,96.7493873263668,99.7773322305616
"--","Europe","Germany","--","hospitalized + non-hospitalized patients","--","--","*2020",10,"Elecsys Anti-SARS-CoV-2 Roche nucleocapsid IgG IgM","n-290",86,89,96.63,90.46,99.3,"","table 1",TRUE,"N","IgG IgM IgA","CMIA","sandwich",FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,67,89,85,89,99.1008991041606,99.3626337826351,96.7639096477475,99.8995325195371
"--","Europe","Germany","--","hospitalized + non-hospitalized patients","--","--","*2020",12,"Elecsys Anti-SARS-CoV-2 Roche nucleocapsid IgG IgM","n-290",84,91,92.31,84.79,96.85,"","table 1",TRUE,"N","IgG IgM IgA","CMIA","sandwich",FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,67,91,87,91,99.2641403624599,99.565443748983,96.7615746090909,99.9545521916771
"--","Europe","Germany","--","hospitalized + non-hospitalized patients","--","--","*2020",14,"Elecsys Anti-SARS-CoV-2 Roche nucleocapsid IgG IgM","n-290",34,35,97.14,85.08,99.93,"","table 1",TRUE,"N","IgG IgM IgA","CMIA","sandwich",FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,67,35,33,35,99.3743245088314,99.7038782016263,96.7642066738659,99.9797495608559
"2.3","East Asia","Japan","Miyagi + Osaka + Tokyo (phase 3), Aichi + Fukuoka (phase 2)","representative","12/3/2021","12/27/2021","2021-12-15",5,"Elecsys Anti-SARS-CoV-2 Roche nucleocapsid IgG IgM","n-280",105,132,79.55,71.65,86.07,NA,"table 4 on page 6",FALSE,"N","IgG IgM IgA","CMIA","sandwich",FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,67,117,99,127,87.8270498413973,88.5242197222512,76.513032971123,95.1264646746102
"1","South Asia","India","Odisha: Bhubaneswar (phase 2), Berhampur, Rourkela","representative","8/6/2020","8/31/2020","8/18/2020",1,"Elecsys Anti-SARS-CoV-2 Roche nucleocapsid IgG IgM","n-93",23,29,79.31,60.28,92.01,"Yes","table 2",TRUE,"N","IgG IgM IgA","CMIA","sandwich",FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,66,28,22,29,93.6158935023605,95.4040706993566,78.1720848280466,99.1378155191032
"2","South Asia","India","Odisha: Bhubaneswar","representative","--","--","8/26/2020",1,"Elecsys Anti-SARS-CoV-2 Roche nucleocapsid IgG IgM","n-94",2,3,66.67,9.43,99.16,"Yes","table 3",TRUE,"N","IgG IgM IgA","CMIA","sandwich",FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,66,3,2,3,93.6761529823879,95.3641939514728,77.8527117858052,99.1862440069314
"3","South Asia","India","Odisha: Bhubaneswar","representative","--","--","9/18/2020",1,"Elecsys Anti-SARS-CoV-2 Roche nucleocapsid IgG IgM","n-94",124,132,93.94,88.41,97.35,"Yes","table 3",TRUE,"N","IgG IgM IgA","CMIA","sandwich",FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,66,126,103,132,93.7546943450457,95.4027685001287,78.8646611685531,99.172439936715
"--","Europe","Ireland","{ Dublin }","hospitalized + non-hospitalized patients","3/26/2020","7/10/2020","5/18/2020",1,"Elecsys Anti-SARS-CoV-2 Roche nucleocapsid IgG IgM","n-225",153,185,82.7,76.47,87.86,"Yes","table 3",TRUE,"N","IgG IgM IgA","CMIA","sandwich",FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,66,177,145,184,93.7701264736385,95.4293804721736,78.7081404882241,99.1745739435111
"--","North America","USA","{ San Francisco }","non-hospitalized patients","*April 2020","*July 2020","--",1,"Elecsys Anti-SARS-CoV-2 Roche nucleocapsid IgG IgM","n-132",147,164,89.6,84.2,93.7,"Not yet","supplementary table 8",TRUE,"N","IgG IgM IgA","CMIA","sandwich",FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,66,153,140,160,92.7331527859838,93.1164852482369,86.832591817683,96.5593044346655
"--","Oceania","Australia","{ Victoria }","hospitalized + non-hospitalized patients","--","--","--",1,"Elecsys Anti-SARS-CoV-2 Roche nucleocapsid IgG IgM","n-240",39,42,92.86,80.52,98.5,"Yes","table 1",TRUE,"N","IgG IgM IgA","CMIA","sandwich",FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,66,41,37,42,96.9587701587119,97.3997227965826,92.1724268662575,99.2870117869784
"1","Europe","Italy","Vo'","representative","5/1/2020","5/3/2020","5/2/2020",2,"Elecsys Anti-SARS-CoV-2 Roche nucleocapsid IgG IgM","n-108",62,62,100,94.22,100,"Yes","supplementary table 2",TRUE,"N","IgG IgM IgA","CMIA","sandwich",FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,66,59,47,62,93.5047112666669,95.1957744168241,77.9267644326871,99.1221528026752
"--","Oceania","Australia","{ Victoria }","hospitalized + non-hospitalized patients","--","--","--",2,"Elecsys Anti-SARS-CoV-2 Roche nucleocapsid IgG IgM","n-240",39,39,100,90.97,100,"Yes","table 1",TRUE,"N","IgG IgM IgA","CMIA","sandwich",FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,66,38,35,39,96.8677660058995,97.2709905360644,92.2924373346663,99.2302885559403
"1","Europe","Iceland","National","convenience (general population)","4/3/2020","7/8/2020","5/21/2020",3,"Elecsys Anti-SARS-CoV-2 Roche nucleocapsid IgG IgM","n-157",1120,1215,92.18,90.53,93.63,"Yes","tables S1 and S4, page 8 of appendix 1",TRUE,"N","IgG IgM IgA","CMIA","sandwich",FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,66,1154,939,1204,93.2399488414325,94.9997614422098,77.502531717935,99.0475226360041
"--","North America","USA","{ ? }","non-hospitalized patients","--","--","--",3,"Elecsys Anti-SARS-CoV-2 Roche nucleocapsid IgG IgM","n-134",40,41,97.56,87.14,99.94,"Yes","",TRUE,"N","IgG IgM IgA","CMIA","sandwich",FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,66,39,31,41,93.3272737407316,95.0029320113032,77.842462406202,99.0680839822383
"--","North America","USA","{ San Francisco }","non-hospitalized patients","--","--","--",3,"Elecsys Anti-SARS-CoV-2 Roche nucleocapsid IgG IgM","n-132",150,166,90.2,85,94.2,"Not yet","supplementary table 8",TRUE,"N","IgG IgM IgA","CMIA","sandwich",FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,66,154,143,161,92.284019585638,92.4885071583897,87.8408688240539,95.5103991725452
"--","Europe","Germany","--","hospitalized + non-hospitalized patients","--","--","*2020",1,"Elecsys Anti-SARS-CoV-2 Roche nucleocapsid IgG IgM","n-290",32,39,82.05,66.47,92.46,"","table 1",TRUE,"N","IgG IgM IgA","CMIA","sandwich",FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,66,38,35,39,97.3664882132768,97.6854436435071,93.7146069107724,99.2158363017058
"--","Europe","Germany","--","hospitalized + non-hospitalized patients","--","--","*2020",2,"Elecsys Anti-SARS-CoV-2 Roche nucleocapsid IgG IgM","n-290",193,194,99.48,97.16,99.99,"","table 1",TRUE,"N","IgG IgM IgA","CMIA","sandwich",FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,66,189,181,194,97.3157257484265,97.5773396700787,94.0791665431688,99.0873679902122
"--","Europe","Germany","--","hospitalized + non-hospitalized patients","--","--","*2020",4,"Elecsys Anti-SARS-CoV-2 Roche nucleocapsid IgG IgM","n-290",123,123,100,97.05,100,"","table 1",TRUE,"N","IgG IgM IgA","CMIA","sandwich",FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,66,120,114,123,97.1828630105104,97.3450333845011,94.6769358257057,98.7854019263908
"1","South Asia","India","Puducherry: Puducherry district","representative","8/11/2020","8/16/2020","2020-08-13",1,"Elecsys Anti-SARS-CoV-2 Roche nucleocapsid IgG IgM","n-87",3,3,100,29.24,100,NA,"",FALSE,"N","IgG IgM IgA","CMIA","sandwich",FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,66,3,2,3,93.7279845332428,95.4094533219984,77.9580385838317,99.1686066543617
"2","South Asia","India","Puducherry: Puducherry district","representative","9/10/2020","9/16/2020","2020-09-13",1,"Elecsys Anti-SARS-CoV-2 Roche nucleocapsid IgG IgM","n-87",3,7,42.86,9.899,81.59,NA,"",FALSE,"N","IgG IgM IgA","CMIA","sandwich",FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,66,7,5,7,93.6967007989025,95.355459034289,78.1100396985301,99.1996718905336
"3","South Asia","India","Puducherry: Puducherry district","representative","10/12/2020","10/16/2020","2020-10-14",1,"Elecsys Anti-SARS-CoV-2 Roche nucleocapsid IgG IgM","n-87",25,29,86.21,68.34,96.11,NA,"",FALSE,"N","IgG IgM IgA","CMIA","sandwich",FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,66,28,22,29,93.7795596265912,95.481412472188,78.4796137633393,99.1805168947645
"1","Oceania","Indonesia","Tanjung Priok sub-district","convenience (general population)","11/23/2020","2/19/2021","2021-01-06",2,"Elecsys Anti-SARS-CoV-2 Roche nucleocapsid IgG IgM","n-152",27,32,84.38,67.21,94.72,NA,"table 2 (excluded 17 samples for taken within 14 days)",FALSE,"N","IgG IgM IgA","CMIA","sandwich",FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,66,31,24,32,93.4649192797506,95.2016205715192,77.2092701092232,99.0987560031097
"1","South Asia","India","Hyderabad","representative","1/8/2021","1/24/2021","2021-01-16",4,"Elecsys Anti-SARS-CoV-2 Roche nucleocapsid IgG IgM","n-101",260,298,87.25,82.92,90.82,NA,"table 2",FALSE,"N","IgG IgM IgA","CMIA","sandwich",FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,66,282,229,296,93.0719590940452,94.8031431226903,77.0249014820055,98.9836745078174
"3.4","East Asia","Japan","Miyagi + Osaka + Tokyo (phase 4), Aichi + Fukuoka (phase 3)","representative","2/2/2022","3/6/2022","2022-02-18",1,"Elecsys Anti-SARS-CoV-2 Roche nucleocapsid IgG IgM","n-280",178,230,77.39,71.43,82.63,NA,"table 4 on page 6",FALSE,"N","IgG IgM IgA","CMIA","sandwich",FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,66,193,166,212,83.6209706389039,84.05792268332,73.4388164630313,91.1849431705964
"--","Europe","Germany","Dresden","hospitalized + non-hospitalized patients","*August 2020","*October 2020","*September 2020",5,"Euroimmun anti-spike","n-133",90,109,82.57,74.13,89.17,"Yes","table 2",TRUE,"S","IgG IgA","ELISA","indirect",FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,65,87,43,105,76.921850741945,80.218766759317,41.1624214190253,95.6966831435766
"--","Europe","Germany","{ Cologne }","hospitalized + non-hospitalized patients","*August 2020","*September 2020","--",5,"Euroimmun anti-spike","n-222",280,363,77.13,72.46,81.36,"Yes","supplementary table S2",TRUE,"S","IgG IgA","ELISA","indirect",FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,65,291,150,349,76.9133410192472,80.1824922679961,41.7159515096652,95.8230854308664
"--","Europe","Germany","{ Saarland }","non-hospitalized patients","--","*October 2020","*October 2020",6,"Euroimmun anti-spike","n-289",23,30,76.67,57.72,90.07,"Yes","figure 2g",TRUE,"S","IgG IgA","ELISA","indirect",FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,65,23,10,30,74.6117547631182,77.9874591489306,36.8905046416589,95.5106548460571
"--","Europe","Germany","{ Cologne }","hospitalized + non-hospitalized patients","--","--","--",7,"Euroimmun anti-spike","n-243",103,131,78.63,70.61,85.3,"Yes","figure 5c, seropositives back-calculated from seroprevalence",TRUE,"S","IgG IgA","ELISA","indirect",FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,65,102,82,117,77.6138007701712,78.1045234055087,64.6783511365903,87.6439604849009
"--","East Asia","South Korea","{ ? }","non-hospitalized patients","--","--","--",8,"Euroimmun anti-spike","n-165",40,58,68.97,55.46,80.46,"Yes","",TRUE,"S","IgG IgA","ELISA","indirect",FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,65,42,16,56,69.5257171210374,72.9169131542443,28.6559435361121,94.430425170806
"--","Europe","Germany","{ Cologne }","hospitalized + non-hospitalized patients","--","12/17/2020","--",9,"Euroimmun anti-spike","n-243",96,131,73.28,64.85,80.63,"Yes","figure 5c, seropositives back-calculated from seroprevalence",TRUE,"S","IgG IgA","ELISA","indirect",FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,65,96,65,116,71.9261115215647,72.8799094627342,51.1793143484098,87.4462739705963
"--","Europe","Germany","Dresden","hospitalized + non-hospitalized patients","*January 2021","*March 2021","*February 2021",10,"Euroimmun anti-spike","n-133",85,109,77.98,69.03,85.35,"Yes","table 2",TRUE,"S","IgG IgA","ELISA","indirect",FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,65,72,21,103,63.3924168979775,66.1389816551568,20.1147212595396,93.8397056302247
"--","Europe","Germany","--","hospitalized + non-hospitalized patients","--","--","*2020",6,"Euroimmun anti-spike","n-290",131,162,80.86,73.95,86.61,"","table 1",TRUE,"S","IgG IgA","ELISA","indirect",FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,65,135,116,149,82.9745566530529,83.3673991209126,73.7205161392165,90.034202073531
"--","Europe","Germany","--","hospitalized + non-hospitalized patients","--","--","*2020",8,"Euroimmun anti-spike","n-290",75,95,78.95,69.38,86.64,"","table 1",TRUE,"S","IgG IgA","ELISA","indirect",FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,65,75,57,87,78.1696623592058,79.0611387446996,62.0651552111305,89.7589558891573
"--","Europe","Germany","--","hospitalized + non-hospitalized patients","--","--","*2020",10,"Euroimmun anti-spike","n-290",71,89,79.78,69.93,87.55,"","table 1",TRUE,"S","IgG IgA","ELISA","indirect",FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,65,66,41,81,72.5210126978633,73.9544968618369,48.196696660857,89.6906465566914
"--","Europe","Germany","--","hospitalized + non-hospitalized patients","--","--","*2020",12,"Euroimmun anti-spike","n-290",66,91,72.53,62.17,81.37,"","table 1",TRUE,"S","IgG IgA","ELISA","indirect",FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,65,62,30,83,66.3180720583112,68.0346797410045,34.096121917571,89.6426400366871
"--","Europe","Germany","--","hospitalized + non-hospitalized patients","--","--","*2020",14,"Euroimmun anti-spike","n-290",27,35,77.14,59.86,89.58,"","table 1",TRUE,"S","IgG IgA","ELISA","indirect",FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,65,22,7,32,59.9384199684608,61.5407388558293,22.3402772172873,89.6015224967593
"1","Europe","Germany","Freiburg + Breisgau-Hochschwarzwald","representative","8/5/2020","9/1/2020","2020-08-18",5,"Euroimmun anti-spike","n-26",12,16,75,47.62,92.73,NA,"page 20",FALSE,"S","IgG IgA","ELISA","indirect",FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,65,13,8,16,77.6197838034331,78.2832517997414,62.7743765387143,88.9339338885249
"1","Europe","Germany","Straubing","representative","9/8/2020","9/26/2020","2020-09-17",5,"Euroimmun anti-spike","n-295 , n-234",17,32,53.12,34.74,70.91,NA,"n-295 (tabelle 3 on page 25)",FALSE,"S","IgG IgA","ELISA","indirect",FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,65,26,12,32,77.1776719864929,80.3142448728807,41.4271730658575,95.8476735606771
"1","Europe","Germany","Aachen","representative","9/9/2020","10/9/2020","2020-09-24",6,"Euroimmun anti-spike","n-26",9,14,64.29,35.14,87.24,NA,"page 20",FALSE,"S","IgG IgA","ELISA","indirect",FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,65,11,6,14,74.9431507743234,75.8073516613302,57.0918708048012,88.4238524150217
"2","Europe","Germany","Reutlingen district","representative","10/14/2020","11/10/2020","2020-10-27",6,"Euroimmun anti-spike","n-26 , n-173",17,21,80.95,58.09,94.55,NA,"n-26 (page 20), n-173 (eSupplement-Table 3)",FALSE,"S","IgG IgA","ELISA","indirect",FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,65,16,7,21,74.4690212504809,77.6511516752328,36.8093923047567,95.3858296561809
"1.2","Europe","Germany","Chemnitz, unvaccinated population","representative","3/3/2021","8/17/2021","2021-05-25",5,"Euroimmun anti-spike","n-173",220,257,85.6,80.71,89.66,NA,"eSupplement-Table 3",FALSE,"S","IgG IgA","ELISA","indirect",FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,65,199,164,225,76.9326268673058,77.356011798307,65.1906435603843,86.3733885970041
"--","Latin America","Brazil","{ Rio de Janeiro city }","hospitalized + non-hospitalized patients","--","--","--",1,"Euroimmun anti-spike","n-170",53,54,98.15,90.11,99.95,"","table 1 (not yet included in seroreversion paper)",TRUE,"S","IgG IgA","ELISA","indirect",FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,64,45,26,53,80.479251549577,83.1084438484873,51.2769640491943,95.8823879266448
"--","Latin America","Brazil","{ Rio de Janeiro city }","hospitalized + non-hospitalized patients","--","--","--",2,"Euroimmun anti-spike","n-170",104,104,100,96.52,100,"Yes","table 1",TRUE,"S","IgG IgA","ELISA","indirect",FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,64,85,50,101,79.7012458158669,82.1613794409145,49.313108030283,95.7581160659453
"--","Europe","Netherlands","{ ? }","convenience (general population)","4/14/2020","--","--",2,"Euroimmun anti-spike","n-226",83,85,97.65,91.76,99.71,"Yes","",TRUE,"S","IgG IgA","ELISA","indirect",FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,64,70,41,82,79.8099271160554,82.5351563816142,49.7889953896819,95.5897917483129
"--","Europe","Germany","{ Cologne }","hospitalized + non-hospitalized patients","4/6/2020","--","--",2,"Euroimmun anti-spike","n-243",113,131,86.26,79.16,91.65,"Yes","figure 5c, seropositives back-calculated from seroprevalence",TRUE,"S","IgG IgA","ELISA","indirect",FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,64,108,94,119,82.3569231086884,82.6482420820915,74.9829581478767,88.2440512245284
"--","Oceania","Australia","{ Sydney }","hospitalized + non-hospitalized patients","*March 2020","*August 2020","--",2,"Euroimmun anti-spike","n-215",121,166,72.89,65.46,79.49,"Yes","table 2",TRUE,"S","IgG IgA","ELISA","indirect",FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,64,136,81,160,79.6092735851888,82.1788918884729,49.686962627247,95.4658609439523
"1","Europe","Germany","National (SOEP)","representative","--","--","11/11/2020",2,"Euroimmun anti-spike","n-68 , n-70",82,133,61.65,52.83,69.95,"Yes","pages 8 and 9",TRUE,"S","IgG IgA","ELISA","indirect",FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,64,109,65,128,79.6127237059969,82.0555910612106,50.0530505505767,95.7196971727731
"--","Europe","Germany","{ Cologne }","hospitalized + non-hospitalized patients","--","--","--",4,"Euroimmun anti-spike","n-243",113,131,86.26,79.16,91.65,"Yes","figure 5c, seropositives back-calculated from seroprevalence",TRUE,"S","IgG IgA","ELISA","indirect",FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,64,106,93,116,80.4302375635886,80.6241506186914,74.254605442093,85.7823145234784
"--","Europe","Netherlands","{ ? }","convenience (general population)","--","8/15/2020","--",4,"Euroimmun anti-spike","n-226",73,85,85.88,76.64,92.49,"Yes","",TRUE,"S","IgG IgA","ELISA","indirect",FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,64,68,39,82,77.7177419177153,80.2810817117978,47.1254978076018,95.0224708655538
"--","Europe","Germany","--","hospitalized + non-hospitalized patients","--","--","*2020",1,"Euroimmun anti-spike","n-290",33,39,84.62,69.47,94.14,"","table 1",TRUE,"S","IgG IgA","ELISA","indirect",FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,64,34,28,38,85.8261319493758,86.169406387199,78.4762957147835,91.4993601071937
"--","Europe","Germany","--","hospitalized + non-hospitalized patients","--","--","*2020",2,"Euroimmun anti-spike","n-290",176,194,90.72,85.73,94.41,"","table 1",TRUE,"S","IgG IgA","ELISA","indirect",FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,64,166,148,179,85.062964836868,85.3259693091314,78.2881048831658,90.5368552653153
"--","Europe","Germany","--","hospitalized + non-hospitalized patients","--","--","*2020",4,"Euroimmun anti-spike","n-290",108,123,87.8,80.68,93.01,"","table 1",TRUE,"S","IgG IgA","ELISA","indirect",FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,64,103,92,112,83.3995223357617,83.5318391071813,77.7982710287314,88.2210882790325
"1","Europe","Austria","Ischgl","representative","4/21/2020","4/27/2020","2020-04-24",1,"Euroimmun anti-spike","n-109",98,105,93.33,86.75,97.28,NA,"table 2",FALSE,"S","IgG IgA","ELISA","indirect",FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,64,87,53,102,80.6333618202546,83.0659014152499,51.8530512410966,95.9219180055414
"1","Europe","France","National","representative","--","--","2020-05-21",3,"Euroimmun anti-spike","n-149",74,83,89.16,80.41,94.92,NA,"table 2",FALSE,"S","IgG IgA","ELISA","indirect",FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,64,67,38.9750000000001,80,78.4447015541824,80.9274986747544,47.0575320398308,95.2800188226912
"1","Europe","France","Grand Est, Île-de-France, Nouvelle-Aquitaine","representative","5/4/2020","6/23/2020","2020-05-29",1,"Euroimmun anti-spike","n-31",68,78,87.18,77.68,93.68,NA,"table 2",FALSE,"S","IgG IgA","ELISA","indirect",FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,64,65,39,76,80.6979612381783,83.1944775666257,51.6131015666266,95.8334980862075
"1","Europe","Germany","Kupferzell","representative","5/20/2020","6/9/2020","2020-05-30",2,"Euroimmun anti-spike","n-110 , n-295",43,50,86,73.26,94.18,NA,"table 3",FALSE,"S","IgG IgA","ELISA","indirect",FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,64,41,24,49,79.8412629139743,82.4175029747065,50.2924863252079,95.5885031554228
"1","Europe","Germany","Bad Feilnbach","representative","6/23/2020","7/4/2020","2020-06-28",3,"Euroimmun anti-spike","n-295",22,42,52.38,36.42,68,NA,"n-295 (tabelle 3 on page 25)",FALSE,"S","IgG IgA","ELISA","indirect",FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,64,34,19,41,78.563772697761,81.0501610569601,48.2268067573735,95.3112604412009
"1","South Asia","India","Pune (five prabhags/subwards)","representative","7/20/2020","8/5/2020","2020-07-28",1,"Euroimmun anti-spike","n-84",19,21,90.48,69.62,98.83,NA,"tables 1 and 2",FALSE,"S","IgG IgA","ELISA","indirect",FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,64,18,10,21,80.7052210652361,83.3437643421713,50.9730891779045,95.8779206064236
"1","Europe","Germany","Reutlingen district","representative","7/1/2020","7/28/2020","2020-07-14",3,"Euroimmun anti-spike","n-26",10,11,90.91,58.72,99.77,NA,"page 20",FALSE,"S","IgG IgA","ELISA","indirect",FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,64,8,5,11,75.2286943728654,75.738232678886,61.0452991481626,86.8071933452407
"1","Europe","Germany","Osnabrück district + Osnabrück city","representative","10/15/2020","11/15/2020","2020-10-30",3,"Euroimmun anti-spike","n-26",11,17,64.71,38.33,85.79,NA,"page 20",FALSE,"S","IgG IgA","ELISA","indirect",FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,64,13,8,16,75.2286943728654,75.738232678886,61.0452991481626,86.8071933452407
"1","Europe","Germany","Mitte (in Berlin)","representative","11/17/2020","12/5/2020","2020-11-26",1,"Euroimmun anti-spike","n-295 , n-236",21,35,60,42.11,76.13,NA,"n-295 (tabelle 3 on page 25)",FALSE,"S","IgG IgA","ELISA","indirect",FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,64,29,17,35,80.7387664910425,83.3182842755377,51.5078317847021,95.9599729182452
"2","Europe","Germany","Freiburg + Breisgau-Hochschwarzwald","representative","11/18/2020","12/15/2020","2020-12-01",2,"Euroimmun anti-spike","n-26 , n-173",10,11,90.91,58.72,99.77,NA,"n-26 (page 20), n-173 (eSupplement-Table 3)",FALSE,"S","IgG IgA","ELISA","indirect",FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,64,9,4,11,79.4819207363038,82.028719424639,49.5630478148237,95.6306814016902
"1","Europe","Germany","Magdeburg","representative","11/18/2020","12/15/2020","2020-12-01",1,"Euroimmun anti-spike","n-26",26,28,92.86,76.5,99.12,NA,"page 20",FALSE,"S","IgG IgA","ELISA","indirect",FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,64,22,16,26,77.5281022568003,78.1122998497945,63.4212272833532,88.6082037796266
"2","Europe","Germany","Aachen region, unvaccinated population","representative","1/25/2021","2/27/2021","2021-02-10",3,"Euroimmun anti-spike","n-26 , n-173",61,70,87.14,76.99,93.95,NA,"n-26 (page 20), n-173 (eSupplement-Table 3)",FALSE,"S","IgG IgA","ELISA","indirect",FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,64,57,33,68,78.6220953934986,81.026037083155,48.4421054393545,95.3008632569497
"2","Europe","Germany","Osnabrück district + Osnabrück city, unvaccinated population","representative","3/1/2021","3/31/2021","2021-03-16",3,"Euroimmun anti-spike","n-26 , n-173",34,37,91.89,78.09,98.3,NA,"n-26 (page 20), n-173 (eSupplement-Table 3)",FALSE,"S","IgG IgA","ELISA","indirect",FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,64,30,17,36,78.5975921801342,81.1329734158858,48.2742330487422,95.1565432726814
"2","Europe","Germany","Magdeburg, unvaccinated population","representative","4/7/2021","5/5/2021","2021-04-21",3,"Euroimmun anti-spike","n-26 , n-173",33,40,82.5,67.22,92.66,NA,"n-26 (page 20), n-173 (eSupplement-Table 3)",FALSE,"S","IgG IgA","ELISA","indirect",FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,64,32,18,39,78.695384931776,81.3258220330564,48.5124873739231,95.2494367153754
"1","Europe","Germany","Vorpommern-Greifswald, unvaccinated population","representative","5/12/2021","6/8/2021","2021-05-25",3,"Euroimmun anti-spike","n-173",70,86,81.4,71.55,88.98,NA,"eSupplement-Table 3",FALSE,"S","IgG IgA","ELISA","indirect",FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,64,75,67,81,86.8538676402424,86.965569346913,82.4357460714525,90.6755445216927
"--","Oceania","Australia","{ Victoria }","hospitalized + non-hospitalized patients","--","--","--",6,"Diasorin Liaison S1/S2 spike IgG","n-240",39,44,88.64,75.44,96.21,"Yes","table 1",TRUE,"S","IgG","CMIA","indirect",FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,63,39,32,43,86.8274486357172,87.3353013222513,76.6664183665863,93.9208109728418
"--","North America","USA","{ San Francisco }","non-hospitalized patients","--","--","--",7,"Diasorin Liaison S1/S2 spike IgG","n-132",49,71,68.7,57.2,79.1,"Not yet","supplementary table 8",TRUE,"S","IgG","CMIA","indirect",FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,63,53,43,62,75.0156846026592,75.2440363272428,65.2192111990121,83.4397619986521
"--","Europe","Germany","Dresden","hospitalized + non-hospitalized patients","*January 2021","*March 2021","*February 2021",10,"Diasorin Liaison S1/S2 spike IgG","n-133",91,109,83.49,75.16,89.91,"Yes","table 2",TRUE,"S","IgG","CMIA","indirect",FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,63,80,60,95,72.7397801435397,73.2029626949147,57.3813235846961,85.1449060721921
"--","Europe","Germany","--","hospitalized + non-hospitalized patients","--","--","*2020",6,"Diasorin Liaison S1/S2 spike IgG","n-290",137,162,84.57,78.07,89.76,"","table 1",TRUE,"S","IgG","CMIA","indirect",FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,63,138,122,149,84.7121287964805,84.9122776508309,77.9217402592094,90.2712776824249
"--","Europe","Germany","--","hospitalized + non-hospitalized patients","--","--","*2020",8,"Diasorin Liaison S1/S2 spike IgG","n-290",84,95,88.42,80.23,94.08,"","table 1",TRUE,"S","IgG","CMIA","indirect",FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,63,78,65,88,81.9749864275169,82.4156397946082,71.0126269320385,90.2619363954823
"--","Europe","Germany","--","hospitalized + non-hospitalized patients","--","--","*2020",10,"Diasorin Liaison S1/S2 spike IgG","n-290",78,89,87.64,78.96,93.67,"","table 1",TRUE,"S","IgG","CMIA","indirect",FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,63,71,54,82,78.8205537737313,79.5965924561211,62.486410005184,90.4754610754764
"--","Europe","Germany","--","hospitalized + non-hospitalized patients","--","--","*2020",12,"Diasorin Liaison S1/S2 spike IgG","n-290",72,91,79.12,69.33,86.94,"","table 1",TRUE,"S","IgG","CMIA","indirect",FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,63,70,47,84,75.2904820580698,76.4737331079341,53.0393836949076,90.7475591622837
"--","Europe","Germany","--","hospitalized + non-hospitalized patients","--","--","*2020",14,"Diasorin Liaison S1/S2 spike IgG","n-290",30,35,85.71,69.74,95.19,"","table 1",TRUE,"S","IgG","CMIA","indirect",FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,63,26,14,33,71.4667945768725,73.0891806805237,43.174483412938,91.0155977610664
"--","North America","USA","{ San Francisco }","non-hospitalized patients","*April 2020","*July 2020","--",1,"Diasorin Liaison S1/S2 spike IgG","n-132",121,140,86.5,80,91.5,"Not yet","supplementary table 8",TRUE,"S","IgG","CMIA","indirect",FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,62,107,84,124,75.9647707629567,76.5585937656035,62.1663291330552,86.7237107663696
"--","Oceania","Australia","{ Victoria }","hospitalized + non-hospitalized patients","--","--","--",1,"Diasorin Liaison S1/S2 spike IgG","n-240",37,42,88.1,74.37,96.02,"Yes","table 1",TRUE,"S","IgG","CMIA","indirect",FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,62,38,32,42,89.8439734152394,90.5056985277376,79.9396072542291,96.2108967437289
"--","Oceania","Australia","{ Sydney }","hospitalized + non-hospitalized patients","*March 2020","*August 2020","--",2,"Diasorin Liaison S1/S2 spike IgG","n-215",134,166,80.72,73.89,86.43,"Yes","table 2",TRUE,"S","IgG","CMIA","indirect",FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,62,145,88.9750000000001,163,84.4139836178729,87.5349755158905,53.9569551382268,97.7337156585446
"1","Europe","Italy","Vo'","representative","5/1/2020","5/3/2020","5/2/2020",2,"Diasorin Liaison S1/S2 spike IgG","n-108",53,62,85.48,74.22,93.14,"Yes","supplementary table 2",TRUE,"S","IgG","CMIA","indirect",FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,62,54,32,61,84.3889594763727,87.5328637622904,54.1934285957593,97.754693294168
"--","Oceania","Australia","{ Victoria }","hospitalized + non-hospitalized patients","--","--","--",2,"Diasorin Liaison S1/S2 spike IgG","n-240",36,39,92.31,79.13,98.38,"Yes","table 1",TRUE,"S","IgG","CMIA","indirect",FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,62,35,29,39,89.457675485944,90.0752036569562,79.6777861877056,95.921742169885
"--","North America","USA","{ ? }","non-hospitalized patients","--","--","--",3,"Diasorin Liaison S1/S2 spike IgG","n-134",38,41,92.68,80.08,98.46,"Yes","",TRUE,"S","IgG","CMIA","indirect",FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,62,36,20,41,83.9115419362896,86.9976129985306,52.2388219860224,97.6306710085791
"--","North America","USA","{ San Francisco }","non-hospitalized patients","--","--","--",3,"Diasorin Liaison S1/S2 spike IgG","n-132",135,166,81.6,75,87,"Not yet","supplementary table 8",TRUE,"S","IgG","CMIA","indirect",FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,62,124,100,143,74.351916974682,74.7456549732168,62.3586002635809,84.3214695691116
"--","Oceania","Australia","{ Victoria }","hospitalized + non-hospitalized patients","--","--","--",4.5,"Diasorin Liaison S1/S2 spike IgG","n-240",11,11,100,71.51,100,"Yes","table 1",TRUE,"S","IgG","CMIA","indirect",FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,62,10,7,11,88.3769383836583,88.878284909971,78.6931448014386,95.2734521634942
"--","Europe","Germany","Dresden","hospitalized + non-hospitalized patients","*August 2020","*October 2020","*September 2020",5,"Diasorin Liaison S1/S2 spike IgG","n-133",88,109,80.73,72.07,87.66,"Yes","table 2",TRUE,"S","IgG","CMIA","indirect",FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,62,95,82,103,86.2752338297045,86.6576844286696,77.9286028988835,92.3618458952693
"--","Europe","Germany","{ Cologne }","hospitalized + non-hospitalized patients","*August 2020","*September 2020","--",5,"Diasorin Liaison S1/S2 spike IgG","n-222",295,363,81.27,76.87,85.15,"Yes","supplementary table S2",TRUE,"S","IgG","CMIA","indirect",FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,62,312,183,355,82.6864484424635,85.8652706080854,50.668496177602,97.3418081334818
"--","North America","USA","{ San Francisco }","non-hospitalized patients","--","--","--",5,"Diasorin Liaison S1/S2 spike IgG","n-132",94,125,75.7,67.5,82.8,"Not yet","supplementary table 8",TRUE,"S","IgG","CMIA","indirect",FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,62,91,74,106,72.5947578723381,72.8986243229755,61.6833812130803,82.0718005142383
"--","Europe","Germany","--","hospitalized + non-hospitalized patients","--","--","*2020",1,"Diasorin Liaison S1/S2 spike IgG","n-290",31,39,79.49,63.54,90.7,"","table 1",TRUE,"S","IgG","CMIA","indirect",FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,62,35,29,38,88.8535391726176,89.2979649838866,80.8199830109099,94.3531326181914
"--","Europe","Germany","--","hospitalized + non-hospitalized patients","--","--","*2020",2,"Diasorin Liaison S1/S2 spike IgG","n-290",172,194,88.66,83.34,92.76,"","table 1",TRUE,"S","IgG","CMIA","indirect",FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,62,172,155,184,88.4695998043447,88.8276536423299,81.2437530529116,93.6874292040024
"--","Europe","Germany","--","hospitalized + non-hospitalized patients","--","--","*2020",4,"Diasorin Liaison S1/S2 spike IgG","n-290",112,123,91.06,84.56,95.45,"","table 1",TRUE,"S","IgG","CMIA","indirect",FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,62,108,97,116,87.6228929372171,87.8216903682954,81.9777638786235,92.1560407920901
"--","North America","USA","{ San Francisco }","non-hospitalized patients","--","--","--",7,"Vitros Ortho total Ig anti-spike","n-132",158,162,97.8,94.7,99.3,"Not yet","supplementary table 8",TRUE,"RBD","IgG IgM IgA etc.","CMIA","sandwich",TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,61,156,149,161,96.117897029244,96.2485715055693,93.4506217966622,98.0122728431982
"--","Europe","Germany","--","hospitalized + non-hospitalized patients","--","--","*2020",8,"Vitros Ortho total Ig anti-spike","n-290",90,95,94.74,88.14,98.27,"","table 1",TRUE,"RBD","IgG IgM IgA etc.","CMIA","sandwich",TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,61,94,92,95,99.0877560243773,99.1441279526779,98.2482351995607,99.6159802090881
"--","Europe","Germany","--","hospitalized + non-hospitalized patients","--","--","*2020",10,"Vitros Ortho total Ig anti-spike","n-290",86,89,96.63,90.46,99.3,"","table 1",TRUE,"RBD","IgG IgM IgA etc.","CMIA","sandwich",TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,61,89,87,89,99.5618688396087,99.6082531960223,98.9984954789566,99.8597224379406
"--","Europe","Germany","--","hospitalized + non-hospitalized patients","--","--","*2020",12,"Vitros Ortho total Ig anti-spike","n-290",88,91,96.7,90.67,99.31,"","table 1",TRUE,"RBD","IgG IgM IgA etc.","CMIA","sandwich",TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,61,91,90,91,99.7869428942397,99.8211432763331,99.4294980443824,99.949734801506
"--","Europe","Germany","--","hospitalized + non-hospitalized patients","--","--","*2020",14,"Vitros Ortho total Ig anti-spike","n-290",35,35,100,90,100,"","table 1",TRUE,"RBD","IgG IgM IgA etc.","CMIA","sandwich",TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,61,35,34,35,99.8949761908099,99.9185389532432,99.674129586551,99.9821037708016
"--","North America","USA","{ San Francisco }","non-hospitalized patients","*April 2020","*July 2020","--",1,"Vitros Ortho total Ig anti-spike","n-132",86,126,68.5,60,76.5,"Not yet","supplementary table 8",TRUE,"RBD","IgG IgM IgA etc.","CMIA","sandwich",TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,60,116,96,124,90.7036363834846,91.9764145903714,77.0655284586481,97.5625657672543
"--","North America","USA","{ San Francisco }","non-hospitalized patients","--","--","--",3,"Vitros Ortho total Ig anti-spike","n-132",132,157,83.9,77.5,89.2,"Not yet","supplementary table 8",TRUE,"RBD","IgG IgM IgA etc.","CMIA","sandwich",TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,60,148,134,155,93.8646656575646,94.4627595336566,86.214140356296,98.0764807883285
"--","North America","USA","{ San Francisco }","non-hospitalized patients","--","--","--",5,"Vitros Ortho total Ig anti-spike","n-132",139,149,93.4,88.6,96.7,"Not yet","supplementary table 8",TRUE,"RBD","IgG IgM IgA etc.","CMIA","sandwich",TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,60,144,135,148,95.9481569987845,96.2362434165158,91.6939119004763,98.5789409799559
"--","Europe","Germany","--","hospitalized + non-hospitalized patients","--","--","*2020",1,"Vitros Ortho total Ig anti-spike","n-290",33,39,84.62,69.47,94.14,"","table 1",TRUE,"RBD","IgG IgM IgA etc.","CMIA","sandwich",TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,60,32,20,38,80.772314776273,83.0045407061587,53.5915745907235,95.2457676612155
"--","Europe","Germany","--","hospitalized + non-hospitalized patients","--","--","*2020",2,"Vitros Ortho total Ig anti-spike","n-290",180,194,92.78,88.19,96,"","table 1",TRUE,"RBD","IgG IgM IgA etc.","CMIA","sandwich",TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,60,166,119,187,83.9599662347188,85.6974784268712,62.2150093140744,95.5476657212926
"--","Europe","Germany","--","hospitalized + non-hospitalized patients","--","--","*2020",4,"Vitros Ortho total Ig anti-spike","n-290",118,123,95.93,90.77,98.67,"","table 1",TRUE,"RBD","IgG IgM IgA etc.","CMIA","sandwich",TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,60,111,93,120,89.1319758161986,90.03324352942,76.6840297426493,96.1567413957992
"--","Europe","Germany","--","hospitalized + non-hospitalized patients","--","--","*2020",6,"Vitros Ortho total Ig anti-spike","n-290",158,162,97.53,93.8,99.32,"","table 1",TRUE,"RBD","IgG IgM IgA etc.","CMIA","sandwich",TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,60,151,138,159,92.7691608323472,93.1679762529263,86.3974660763339,96.8090584500252
"--","Europe","Germany","--","hospitalized + non-hospitalized patients","--","--","*2020",6,"Wantai ELISA SARS-CoV-2 Total Antibody, IgG IgM anti-RBD","n-290",160,162,98.77,95.61,99.85,"","table 1",TRUE,"RBD","IgG IgM","ELISA","sandwich",TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,59,161,157,162,99.0444756754781,99.1536566964319,97.7646784448986,99.6942373489702
"--","Europe","Germany","--","hospitalized + non-hospitalized patients","--","--","*2020",8,"Wantai ELISA SARS-CoV-2 Total Antibody, IgG IgM anti-RBD","n-290",95,95,100,96.19,100,"","table 1",TRUE,"RBD","IgG IgM","ELISA","sandwich",TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,59,95,92,95,99.3939192059684,99.5209550423637,98.1742038372018,99.8784496097614
"--","Europe","Germany","--","hospitalized + non-hospitalized patients","--","--","*2020",10,"Wantai ELISA SARS-CoV-2 Total Antibody, IgG IgM anti-RBD","n-290",88,89,98.88,93.9,99.97,"","table 1",TRUE,"RBD","IgG IgM","ELISA","sandwich",TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,59,89,87,89,99.596658822598,99.7292350045059,98.4379878008158,99.9518115256996
"--","Europe","Germany","--","hospitalized + non-hospitalized patients","--","--","*2020",12,"Wantai ELISA SARS-CoV-2 Total Antibody, IgG IgM anti-RBD","n-290",91,91,100,96.03,100,"","table 1",TRUE,"RBD","IgG IgM","ELISA","sandwich",TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,59,91,89,91,99.7177557869606,99.8479340692511,98.6597867163261,99.9815419981375
"--","Europe","Germany","--","hospitalized + non-hospitalized patients","--","--","*2020",14,"Wantai ELISA SARS-CoV-2 Total Antibody, IgG IgM anti-RBD","n-290",35,35,100,90,100,"","table 1",TRUE,"RBD","IgG IgM","ELISA","sandwich",TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,59,35,34,35,99.7919780796926,99.9142224602045,98.8435800454164,99.9929635714709
"1","Europe","Italy","Caldari Ortona (Villa Caldari)","representative","4/18/2020","4/19/2020","4/18/2020",1,"Wantai ELISA SARS-CoV-2 Total Antibody, IgG IgM anti-RBD","n-107",7,7,100,59.04,100,"Yes","",TRUE,"RBD","IgG IgM","ELISA","sandwich",TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,58,7,4,7,90.734904852976,93.5251561007677,66.2720038430427,99.0672797592383
"1 - 4","Europe","Denmark","National (SSI) + 30 municipalities subset","representative","5/18/2020","12/16/2020","9/1/2020",2,"Wantai ELISA SARS-CoV-2 Total Antibody, IgG IgM anti-RBD","n-22",217,232,93.53,89.56,96.34,"Yes","page 719",TRUE,"RBD","IgG IgM","ELISA","sandwich",TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,58,221,172,231,93.1171380244127,95.2689540353283,74.3975650759342,99.3597981816366
"1","Europe","Iceland","{ National }","convenience (general population)","4/3/2020","7/8/2020","5/21/2020",3,"Wantai ELISA SARS-CoV-2 Total Antibody, IgG IgM anti-RBD","n-157",1143,1215,94.07,92.6,95.33,"Yes","tables S1 and S4, page 8 of appendix 1",TRUE,"RBD","IgG IgM","ELISA","sandwich",TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,58,1174,973,1210,94.911815048687,96.6054599091811,80.0657198732602,99.5319725715619
"5","Europe","Denmark","National (SSI), unvaccinated population","representative","2/27/2021","4/20/2021","*3/17/2021",4,"Wantai ELISA SARS-CoV-2 Total Antibody, IgG IgM anti-RBD","n-194",484,514,94.16,91.77,96.03,"Yes","page 4",TRUE,"RBD","IgG IgM","ELISA","sandwich",TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,58,502,434,513,96.2845574599044,97.6043446352313,84.6334857357026,99.6701514038459
"6","Europe","Denmark","National (SSI), unvaccinated population","representative","5/14/2021","7/11/2021","*6/10/2021",5,"Wantai ELISA SARS-CoV-2 Total Antibody, IgG IgM anti-RBD","n-195",282,310,90.97,87.21,93.91,"Yes","page 4",TRUE,"RBD","IgG IgM","ELISA","sandwich",TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,58,305,273,310,97.2775935895897,98.2737101410823,88.4154673207875,99.7733182051532
"--","Europe","Germany","--","hospitalized + non-hospitalized patients","--","--","*2020",1,"Wantai ELISA SARS-CoV-2 Total Antibody, IgG IgM anti-RBD","n-290",36,39,92.31,79.13,98.38,"","table 1",TRUE,"RBD","IgG IgM","ELISA","sandwich",TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,58,37,30,39,92.8936181989595,94.0451959133185,80.7536015488548,98.4427129945157
"--","Europe","Germany","--","hospitalized + non-hospitalized patients","--","--","*2020",2,"Wantai ELISA SARS-CoV-2 Total Antibody, IgG IgM anti-RBD","n-290",190,194,97.94,94.81,99.44,"","table 1",TRUE,"RBD","IgG IgM","ELISA","sandwich",TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,58,186,168,193,94.9832808164892,95.6848727097814,87.3311849675236,98.7738612079836
"--","Europe","Germany","--","hospitalized + non-hospitalized patients","--","--","*2020",4,"Wantai ELISA SARS-CoV-2 Total Antibody, IgG IgM anti-RBD","n-290",123,123,100,97.05,100,"","table 1",TRUE,"RBD","IgG IgM","ELISA","sandwich",TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,58,120,114,123,97.5170120793985,97.7762621269659,94.2810753519239,99.286795518084
"--","Europe","Germany","--","hospitalized + non-hospitalized patients","--","--","*2020",8,"GenScript cPass neutralization kit","n-290",90,95,94.74,88.14,98.27,"","table 1",TRUE,"RBD",NA,"NT (protein-protein ELISA)","competitive",TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,57,81,69,89,84.5679624275337,84.943611840865,75.3712461820523,91.4824017026539
"--","Europe","Germany","--","hospitalized + non-hospitalized patients","--","--","*2020",10,"GenScript cPass neutralization kit","n-290",86,89,96.63,90.46,99.3,"","table 1",TRUE,"RBD",NA,"NT (protein-protein ELISA)","competitive",TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,57,73,56,83,80.6259817551514,81.4675587435583,64.8283522490653,91.4779678260285
"--","Oceania","New Zealand","{ Southern District Health Board region }","hospitalized + non-hospitalized patients","3/11/2020","4/5/2020","--",10,"GenScript cPass neutralization kit","n-198",35,37,94.59,81.81,99.34,"Yes","",TRUE,"RBD",NA,"NT (protein-protein ELISA)","competitive",TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,57,31,14,37,80.4064909786666,84.7650749032751,39.8823375643494,97.9985901379778
"--","Europe","Germany","--","hospitalized + non-hospitalized patients","--","--","*2020",12,"GenScript cPass neutralization kit","n-290",82,91,90.11,82.05,95.38,"","table 1",TRUE,"RBD",NA,"NT (protein-protein ELISA)","competitive",TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,57,71,46,85,75.9881717262587,77.4375437525256,52.3727456629866,91.4852921857454
"--","Europe","Germany","--","hospitalized + non-hospitalized patients","--","--","*2020",14,"GenScript cPass neutralization kit","n-290",33,35,94.29,80.84,99.3,"","table 1",TRUE,"RBD",NA,"NT (protein-protein ELISA)","competitive",TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,57,26,13,33,70.8238063643542,72.7634798325816,39.4834961560955,91.5719820941763
"--","Europe","Germany","--","hospitalized + non-hospitalized patients","--","--","*2020",1,"GenScript cPass neutralization kit","n-290",35,39,89.74,75.78,97.13,"","table 1",TRUE,"RBD",NA,"NT (protein-protein ELISA)","competitive",TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,56,37,31,39,93.8103528604199,94.7545027509727,83.1775443955063,98.5534455750896
"--","Europe","Netherlands","{ ? }","convenience (general population)","4/14/2020","--","--",2,"GenScript cPass neutralization kit","n-226",85,85,100,95.75,100,"Yes","",TRUE,"RBD",NA,"NT (protein-protein ELISA)","competitive",TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,56,79,56,85,90.6717278464089,93.2587940324533,66.8265559612034,98.9876901631489
"--","Europe","Germany","--","hospitalized + non-hospitalized patients","--","--","*2020",2,"GenScript cPass neutralization kit","n-290",180,194,92.78,88.19,96,"","table 1",TRUE,"RBD",NA,"NT (protein-protein ELISA)","competitive",TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,56,184,163,192,93.8994073075459,94.6739202915865,84.6606695460431,98.3348072146719
"--","Europe","Netherlands","{ ? }","convenience (general population)","--","8/15/2020","--",4,"GenScript cPass neutralization kit","n-226",83,85,97.65,91.76,99.71,"Yes","",TRUE,"RBD",NA,"NT (protein-protein ELISA)","competitive",TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,56,79,56,85,90.5587926862156,93.0748967722896,67.6556971432301,98.8613238052335
"--","Europe","Germany","--","hospitalized + non-hospitalized patients","--","--","*2020",4,"GenScript cPass neutralization kit","n-290",114,123,92.68,86.56,96.6,"","table 1",TRUE,"RBD",NA,"NT (protein-protein ELISA)","competitive",TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,56,116,105,122,94.0161902765133,94.495562064488,87.2081339267444,97.8100554365075
"--","Europe","Germany","--","hospitalized + non-hospitalized patients","--","--","*2020",6,"GenScript cPass neutralization kit","n-290",139,162,85.8,79.46,90.78,"","table 1",TRUE,"RBD",NA,"NT (protein-protein ELISA)","competitive",TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,56,153,142,159,94.0487721126223,94.3194143806834,89.2497619384066,97.2081607001075
"--","Europe","Germany","--","hospitalized + non-hospitalized patients","--","--","*2020",8,"Euroimmun anti-nucleocapsid IgG IgM","n-290",49,95,51.58,41.1,61.96,"","table 1",TRUE,"N","IgG IgM","ELISA","indirect",FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,55,51,36,65,53.4306072557018,53.3464181705251,42.1641381266531,64.6901388186696
"--","Europe","Germany","--","hospitalized + non-hospitalized patients","--","--","*2020",10,"Euroimmun anti-nucleocapsid IgG IgM","n-290",31,89,34.83,25.04,45.67,"","table 1",TRUE,"N","IgG IgM","ELISA","indirect",FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,55,33,18,50,36.9928053331222,36.5577169327801,23.1351354101556,52.9481812939521
"--","Europe","Germany","--","hospitalized + non-hospitalized patients","--","--","*2020",12,"Euroimmun anti-nucleocapsid IgG IgM","n-290",23,91,25.27,16.75,35.47,"","table 1",TRUE,"N","IgG IgM","ELISA","indirect",FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,55,21,8,40,23.4509019320376,22.5177039695711,11.0450767242518,41.1752375403926
"--","Europe","Germany","--","hospitalized + non-hospitalized patients","--","--","*2020",14,"Euroimmun anti-nucleocapsid IgG IgM","n-290",6,35,17.14,6.562,33.65,"","table 1",TRUE,"N","IgG IgM","ELISA","indirect",FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,55,4,0,12,14.0081321088309,12.7797800985133,4.82629603602062,30.454048640531
"--","Europe","Netherlands","{ ? }","convenience (general population)","4/14/2020","--","--",2,"Euroimmun anti-nucleocapsid IgG IgM","n-226",77,85,90.59,82.29,95.85,"Yes","",TRUE,"N","IgG IgM","ELISA","indirect",FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,54,72,37,84,80.6433475265989,84.2392030567513,44.4704033329435,97.3517582860437
"--","Europe","Netherlands","{ ? }","convenience (general population)","--","8/15/2020","--",4,"Euroimmun anti-nucleocapsid IgG IgM","n-226",71,85,83.53,73.91,90.69,"Yes","",TRUE,"N","IgG IgM","ELISA","indirect",FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,54,64,25,82,71.6536756354165,75.0350964402853,30.4860840152562,95.376646681982
"--","Europe","Germany","--","hospitalized + non-hospitalized patients","--","--","*2020",1,"Euroimmun anti-nucleocapsid IgG IgM","n-290",31,39,79.49,63.54,90.7,"","table 1",TRUE,"N","IgG IgM","ELISA","indirect",FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,54,35,28,38,87.6082513170275,88.4455522162061,75.3262612887174,95.1959497008246
"--","Europe","Germany","--","hospitalized + non-hospitalized patients","--","--","*2020",2,"Euroimmun anti-nucleocapsid IgG IgM","n-290",180,194,92.78,88.19,96,"","table 1",TRUE,"N","IgG IgM","ELISA","indirect",FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,54,165,137,183,84.4321324326781,85.1856122867106,71.5647320725141,93.0926383979352
"--","Europe","Germany","--","hospitalized + non-hospitalized patients","--","--","*2020",4,"Euroimmun anti-nucleocapsid IgG IgM","n-290",105,123,85.37,77.86,91.09,"","table 1",TRUE,"N","IgG IgM","ELISA","indirect",FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,54,94,75,109,75.9546392902929,76.4127883897255,63.0373960459735,86.1674555485162
"--","Europe","Germany","--","hospitalized + non-hospitalized patients","--","--","*2020",6,"Euroimmun anti-nucleocapsid IgG IgM","n-290",108,162,66.67,58.84,73.87,"","table 1",TRUE,"N","IgG IgM","ELISA","indirect",FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,54,105,83,124,64.4665240031841,64.5928525213168,53.5028552522671,74.6140469092907
"--","Europe","Germany","--","hospitalized + non-hospitalized patients","--","--","*2020",8,"Elecsys Anti-SARS-CoV-2 Roche spike","n-290",95,95,100,96.19,100,"","table 1",TRUE,"RBD","IgG IgM IgA","CMIA","sandwich",TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,53,95,94,95,99.835014093963,99.8763594423009,99.4461153242402,99.9854469549996
"--","Europe","Germany","--","hospitalized + non-hospitalized patients","--","--","*2020",10,"Elecsys Anti-SARS-CoV-2 Roche spike","n-290",88,89,98.88,93.9,99.97,"","table 1",TRUE,"RBD","IgG IgM IgA","CMIA","sandwich",TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,53,89,88,89,99.9195253353133,99.9501232963353,99.6610626263651,99.9969766581557
"--","Europe","Germany","--","hospitalized + non-hospitalized patients","--","--","*2020",12,"Elecsys Anti-SARS-CoV-2 Roche spike","n-290",91,91,100,96.03,100,"","table 1",TRUE,"RBD","IgG IgM IgA","CMIA","sandwich",TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,53,91,90,91,99.9586716376309,99.9797961773071,99.7929384423075,99.9993700976551
"--","Europe","Germany","--","hospitalized + non-hospitalized patients","--","--","*2020",14,"Elecsys Anti-SARS-CoV-2 Roche spike","n-290",35,35,100,90,100,"","table 1",TRUE,"RBD","IgG IgM IgA","CMIA","sandwich",TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,53,35,35,35,99.977706544287,99.9918689072731,99.8698102712956,99.999872895774
"--","Europe","Germany","--","hospitalized + non-hospitalized patients","--","--","*2020",1,"Elecsys Anti-SARS-CoV-2 Roche spike","n-290",35,39,89.74,75.78,97.13,"","table 1",TRUE,"RBD","IgG IgM IgA","CMIA","sandwich",TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,52,37,29,39,93.1698706777378,94.7216270447883,78.4611725616453,98.9536011990371
"--","Europe","Germany","--","hospitalized + non-hospitalized patients","--","--","*2020",2,"Elecsys Anti-SARS-CoV-2 Roche spike","n-290",192,194,98.97,96.33,99.87,"","table 1",TRUE,"RBD","IgG IgM IgA","CMIA","sandwich",TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,52,186,163,193,95.0631520571058,96.0964426896481,84.7840590200019,99.1890063696006
"--","Europe","Germany","--","hospitalized + non-hospitalized patients","--","--","*2020",4,"Elecsys Anti-SARS-CoV-2 Roche spike","n-290",123,123,100,97.05,100,"","table 1",TRUE,"RBD","IgG IgM IgA","CMIA","sandwich",TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,52,121,113,123,97.4442104414922,97.9060881634445,92.7021803342772,99.5507337401811
"--","Europe","Germany","--","hospitalized + non-hospitalized patients","--","--","*2020",6,"Elecsys Anti-SARS-CoV-2 Roche spike","n-290",162,162,100,97.75,100,"","table 1",TRUE,"RBD","IgG IgM IgA","CMIA","sandwich",TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,52,160,155,162,98.6622458365095,98.8863825450114,96.3415837324079,99.7806276895757
"1","South Asia","Maldives","greater Male’ area","representative","10/15/2020","11/16/2020","10/31/2020",4,"Vitros Ortho (not total) IgG anti-spike","n-151",77,133,57.89,49.03,66.4,"Yes","table 1",TRUE,"S","IgG","CMIA","indirect",FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,51,111,59,130,79.8116578470145,83.1719476628351,44.8839705276431,96.8976381037894
"--","North America","USA","{ San Francisco }","non-hospitalized patients","--","--","--",5,"Vitros Ortho (not total) IgG anti-spike","n-132",111,147,75.1,67.8,82,"Not yet","supplementary table 8",TRUE,"S","IgG","CMIA","indirect",FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,51,122,102,135,82.0899785031442,82.7297512339006,71.071770574182,89.6626970667226
"--","North America","USA","{ San Francisco }","non-hospitalized patients","--","--","--",7,"Vitros Ortho (not total) IgG anti-spike","n-132",72,113,63.5,54.4,72.4,"Not yet","supplementary table 8",TRUE,"S","IgG","CMIA","indirect",FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,51,89,61,103,76.8937743446264,78.4289769638525,55.6188663129272,89.7258531883393
"6","South Asia","India","Delhi, unvaccinated population","representative","9/24/2021","10/14/2021","2021-10-04",6,"Vitros Ortho (not total) IgG anti-spike","n-153",1739,2143,81.15,79.43,82.78,NA,"table 4",FALSE,"S","IgG","CMIA","indirect",FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,51,1692,745,2065,75.2053448355439,78.9592888204397,34.5892217084326,96.3479860181781
"--","North America","USA","{ San Francisco }","non-hospitalized patients","*April 2020","*July 2020","--",1,"Vitros Ortho (not total) IgG anti-spike","n-132",157,172,91,86.3,95,"Not yet","supplementary table 8",TRUE,"S","IgG","CMIA","indirect",FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,50,143,119,160,82.6701334323921,83.1724339765285,70.5644621188162,91.9267295042737
"--","North America","USA","{ San Francisco }","non-hospitalized patients","--","--","--",3,"Vitros Ortho (not total) IgG anti-spike","n-132",139,165,84.3,78.5,89.8,"Not yet","supplementary table 8",TRUE,"S","IgG","CMIA","indirect",FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,50,130,111,145,78.4587928447408,78.6725379772187,69.5992639200239,86.271148973186
"1","North America","USA","Connecticut","representative","6/10/2020","7/29/2020","2020-07-04",2,"Vitros Ortho (not total) IgG anti-spike","n-2",11,11,100,71.51,100,NA,"table 3",FALSE,"S","IgG","CMIA","indirect",FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,50,9,4,11,79.2892418568562,82.3911802215507,45.2561463688045,96.5227460661637
"5","South Asia","India","Delhi, unvaccinated population","representative","1/11/2021","1/22/2021","2021-01-16",3,"Vitros Ortho (not total) IgG anti-spike","n-86",817,1121,72.88,70.18,75.47,NA,"table 2",FALSE,"S","IgG","CMIA","indirect",FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,50,900,463,1075,77.219722432267,80.2796270358405,41.421407233316,95.8374570689641
"--","Latin America","Brazil","{ Pelotas }","hospitalized + non-hospitalized patients","--","--","*November 2020",3,"University of Rio de Janeiro (UFRJ) anti-spike ELISA","n-171",23,25,92,73.97,99.02,"Yes","",TRUE,"S","IgG","ELISA","indirect",FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,49,23,19,25,91.082255398527,91.7123529548871,81.466332924785,97.085513117132
"--","Latin America","Brazil","{ Pelotas }","hospitalized + non-hospitalized patients","--","--","*November 2020",4,"University of Rio de Janeiro (UFRJ) anti-spike ELISA","n-171",26,26,100,86.77,100,"Yes","",TRUE,"S","IgG","ELISA","indirect",FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,49,24,19,26,90.4909341515767,91.3341146339053,78.7108902857677,97.3195773148602
"--","Latin America","Brazil","{ Pelotas }","hospitalized + non-hospitalized patients","--","--","*November 2020",5,"University of Rio de Janeiro (UFRJ) anti-spike ELISA","n-171",27,31,87.1,70.17,96.37,"Yes","",TRUE,"S","IgG","ELISA","indirect",FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,49,28,22,31,89.7701812553695,90.946047956732,74.9544119503605,97.6558412628607
"--","Latin America","Brazil","{ Pelotas }","hospitalized + non-hospitalized patients","--","--","*November 2020",1,"University of Rio de Janeiro (UFRJ) anti-spike ELISA","n-171",23,26,88.46,69.85,97.55,"Yes","",TRUE,"S","IgG","ELISA","indirect",FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,48,25,21,26,93.4395467102411,93.9904349086675,86.0716850991029,97.6132332287008
"--","Latin America","Brazil","{ Rio de Janeiro city }","hospitalized + non-hospitalized patients","--","--","--",1,"University of Rio de Janeiro (UFRJ) anti-spike ELISA","n-170",54,54,100,93.4,100,"Yes","table 1 (not yet included in seroreversion paper)",TRUE,"S","IgG","ELISA","indirect",FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,48,49,33,54,88.6927266971419,91.5564218501095,62.3030301358092,98.605438019918
"--","Latin America","Brazil","{ Rio de Janeiro city }","hospitalized + non-hospitalized patients","--","--","--",2,"University of Rio de Janeiro (UFRJ) anti-spike ELISA","n-170",107,107,100,96.61,100,"Yes","table 1",TRUE,"S","IgG","ELISA","indirect",FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,48,97,63,106,87.9530370268446,90.9707503397746,60.3831714809679,98.5419486790341
"--","Latin America","Brazil","{ Pelotas }","hospitalized + non-hospitalized patients","--","--","*November 2020",2,"University of Rio de Janeiro (UFRJ) anti-spike ELISA","n-171",24,26,92.31,74.87,99.05,"Yes","",TRUE,"S","IgG","ELISA","indirect",FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,48,24,21,26,93.0735483012443,93.4725993678467,86.6831972358194,97.1252267493855
"3","South Asia","India","National","representative","--","--","12/27/2020",5,"Siemens Advia SARS-CoV-2 IgG anti-RBD","n-96",44,74,59.46,47.41,70.73,"Yes","supplementary table (page 8)",TRUE,"RBD","IgG","CMIA","indirect",TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,47,46,31,59,61.4977180699289,61.9166551152988,44.7140781270451,75.8001029529349
"3","South Asia","India","National","representative","--","--","12/27/2020",7,"Siemens Advia SARS-CoV-2 IgG anti-RBD","n-96",12,23,52.17,30.59,73.18,"N","supplementary table (page 8)",TRUE,"RBD","IgG","CMIA","indirect",TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,47,14,6,20,59.0261322805713,59.9363649771151,32.6514241908863,80.7817645087728
"3","South Asia","India","National","representative","--","--","12/27/2020",1,"Siemens Advia SARS-CoV-2 IgG anti-RBD","n-96",25,38,65.79,48.65,80.37,"Yes","supplementary table (page 8)",TRUE,"RBD","IgG","CMIA","indirect",TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,46,26,16,35,68.7966967340705,69.7098163406934,46.1163220194759,86.9446630497652
"3","South Asia","India","National","representative","--","--","12/27/2020",3,"Siemens Advia SARS-CoV-2 IgG anti-RBD","n-96",60,96,62.5,52.03,72.18,"Yes","supplementary table (page 8)",TRUE,"RBD","IgG","CMIA","indirect",TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,46,63,45,78,64.8509084680746,65.1367368991058,49.7499047616297,78.3191540769241
"--","Europe","Scotland","{ ? }","hospitalized + non-hospitalized patients","*September 2020","*November 2020","--",4,"Roche SARS-CoV-2 rapid antibody test anti-spike anti-nucleocapsid IgG IgM","n-213",41,44,93.18,81.34,98.57,"Yes","table 3",TRUE,"N, S","IgG IgM","LFIA","indirect",FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,45,42,37,44,94.3245122434072,94.8305023498596,87.7094572290758,98.269713002574
"--","Europe","Scotland","{ ? }","hospitalized + non-hospitalized patients","*September 2020","*November 2020","--",6,"Roche SARS-CoV-2 rapid antibody test anti-spike anti-nucleocapsid IgG IgM","n-213",65,79,82.28,72.06,89.96,"Yes","table 3",TRUE,"N, S","IgG IgM","LFIA","indirect",FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,45,73,58,79,90.6332113353402,92.1510627858099,74.6580217283624,98.3973655797009
"--","Europe","Scotland","{ ? }","hospitalized + non-hospitalized patients","*September 2020","*November 2020","--",1,"Roche SARS-CoV-2 rapid antibody test anti-spike anti-nucleocapsid IgG IgM","n-213",30,32,93.75,79.19,99.23,"Yes","table 2",TRUE,"N, S","IgG IgM","LFIA","indirect",FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,44,31,26,32,94.4842703555472,95.0519713502336,87.3259328905882,98.2167655629286
"--","Europe","Scotland","{ ? }","hospitalized + non-hospitalized patients","*September 2020","*November 2020","--",2,"Roche SARS-CoV-2 rapid antibody test anti-spike anti-nucleocapsid IgG IgM","n-213",151,154,98.05,94.41,99.6,"Yes","table 3",TRUE,"N, S","IgG IgM","LFIA","indirect",FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,44,144,131,151,93.1742467072471,93.6254052368163,86.5091881613766,97.2022014378546
"--","Europe","Finland","{ 5 hospital districts }","convenience (general population)","--","--","*October 2020",8,"in-house THL Finland neutralization assay","n-184",335,367,91.28,87.91,93.96,"Yes","5 districts listed in n-181 and are:  Uusimaa [contains Helsinki], Pirkanmaa, Pohjois-Pohjanmaa [a.k.a. North Ostrobothnia], Pohjois-Savo, Varsinais-Suomi",TRUE,"RBD",NA,"NT (cell)","competitive",TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,43,346,243,365,91.4307290718994,94.2833108946277,66.7354891778958,99.2859989797498
"--","Europe","Finland","{ 5 hospital districts }","convenience (general population)","--","--","*May 2021",13,"in-house THL Finland neutralization assay","n-184",320,367,87.19,83.34,90.44,"Yes","5 districts listed in n-181 and are:  Uusimaa [contains Helsinki], Pirkanmaa, Pohjois-Pohjanmaa [a.k.a. North Ostrobothnia], Pohjois-Savo, Varsinais-Suomi",TRUE,"RBD",NA,"NT (cell)","competitive",TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,43,349,203,367,90.7267904117707,95.1186896915972,55.3774539284409,99.7183621986077
"--","Europe","Finland","{ Helsinki }","convenience (general population)","--","--","--",4,"in-house THL Finland neutralization assay","n-183",63,64,98.44,91.6,99.96,"Yes","",TRUE,"RBD",NA,"NT (cell)","competitive",TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,42,58,36,64,86.7198246971049,90.0021537133813,57.0376095361841,98.3757574807021
"--","Europe","Finland","{ 5 hospital districts }","convenience (general population)","*early November 2020","December 2020","--",7,"in-house THL Finland neutralization assay","n-182",792,867,91.35,89.28,93.14,"N","5 districts listed in n-181 and are:  Uusimaa [contains Helsinki], Pirkanmaa, Pohjois-Pohjanmaa [a.k.a. North Ostrobothnia], Pohjois-Savo, Varsinais-Suomi",TRUE,"RBD",NA,"NT (cell)","competitive",TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,42,763,448,851,84.6385866159019,87.9679594803326,51.7462815963528,98.0234213048745
"2","Europe","England","National (REACT-2)","representative","7/31/2020","8/13/2020","2020-08-06",3,"Fortress Diagnostics LFIA COVID-19 total, Northern Ireland (recognizes spike)","n-102",274,360,76.11,71.36,80.42,NA,"supplemental table S3 in file 7",FALSE,"S","IgG IgM","LFIA","indirect",FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,41,254,97,339,67.6302082621285,70.3558245964658,27.1308129795098,94.0059941573929
"3","Europe","England","National (REACT-2)","representative","9/15/2020","9/28/2020","2020-09-21",4,"Fortress Diagnostics LFIA COVID-19 total, Northern Ireland (recognizes spike)","n-102",474,750,63.2,59.64,66.66,NA,"supplemental table S3 in file 7",FALSE,"S","IgG IgM","LFIA","indirect",FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,41,489,148,701,62.5131355334621,65.2063031314762,19.7854513252567,93.3113829759435
"1","Europe","England","National (REACT-2)","representative","6/20/2020","7/13/2020","2020-07-01",2,"Fortress Diagnostics LFIA COVID-19 total, Northern Ireland (recognizes spike)","n-14",277,341,81.23,76.68,85.24,NA,"supplemental table 3",FALSE,"S","IgG IgM","LFIA","indirect",FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,40,275,129,330,76.9444850658566,80.7176290692412,38.1012240252174,96.4315711141544
"4","Europe","England","National (REACT-2)","representative","10/27/2020","11/10/2020","2020-11-03",1,"Fortress Diagnostics LFIA COVID-19 total, Northern Ireland (recognizes spike)","n-15",1094,1765,61.98,59.67,64.25,NA,"table S2",FALSE,"S","IgG IgM","LFIA","indirect",FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,40,1527,885,1725,83.17517505736,86.5463930894257,50.1110740856412,97.6529134671194
"--","Europe","Scotland","{ ? }","hospitalized + non-hospitalized patients","*September 2020","*November 2020","--",4,"Biomerica anti-nucleocapsid IgG IgM rapid test","n-213",39,44,88.64,75.44,96.21,"Yes","table 3",TRUE,"N","IgG IgM","LFIA","indirect",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,39,34,24,41,75.7280664421559,76.3642864188149,58.7150716725733,88.8341354627293
"--","Europe","Scotland","{ ? }","hospitalized + non-hospitalized patients","*September 2020","*November 2020","--",6,"Biomerica anti-nucleocapsid IgG IgM rapid test","n-213",43,79,54.43,42.83,65.69,"Yes","table 3",TRUE,"N","IgG IgM","LFIA","indirect",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,39,42,16,67,52.9804319308467,52.8557085469481,22.0470216051167,83.6774770883998
"--","Europe","Scotland","{ ? }","hospitalized + non-hospitalized patients","*September 2020","*November 2020","--",1,"Biomerica anti-nucleocapsid IgG IgM rapid test","n-213",53,57,92.98,83,98.05,"Yes","table 2",TRUE,"N","IgG IgM","LFIA","indirect",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,38,55,49,57,95.4455667716811,95.9149378485829,89.4891817479927,98.5365763970993
"--","Europe","Scotland","{ ? }","hospitalized + non-hospitalized patients","*September 2020","*November 2020","--",2,"Biomerica anti-nucleocapsid IgG IgM rapid test","n-213",143,157,91.08,85.49,95.04,"Yes","table 3",TRUE,"N","IgG IgM","LFIA","indirect",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,38,146,132,154,92.5320782835022,92.9867016317492,85.5931236027693,96.8774049909766
"--","Latin America","Argentina","{ ? }","hospitalized + non-hospitalized patients","--","*September 2020","--",3,"COVIDAR anti-spike anti-RBD","n-224",113,137,82.48,75.06,88.44,"Yes","table 1",TRUE,"RBD, S","IgG IgM","ELISA","indirect",TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,37,99,78,116,71.7646367234781,72.1418615034638,58.7787272024742,82.6530446869718
"1","Latin America","Argentina","Puerto Madryn","representative","03/03/2021","4/17/2021","2021-03-25",5,"COVIDAR anti-spike anti-RBD","n-248",57,78,73.08,61.84,82.5,NA,"positive on nasal swab (supplemental S2 data)",FALSE,"RBD, S","IgG IgM","ELISA","indirect",TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,37,65,27,77,78.6698239990679,83.1699032385192,35.7306046012172,97.7455809184498
"--","Latin America","Argentina","{ ? }","hospitalized + non-hospitalized patients","--","*September 2020","--",1,"COVIDAR anti-spike anti-RBD","n-224",335,453,73.95,69.65,77.94,"Yes","table 1",TRUE,"RBD, S","IgG IgM","ELISA","indirect",TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,36,387,342,418,85.0305607532589,85.4222852257617,76.3564074243743,91.663394446841
"--","Latin America","Argentina","{ ? }","hospitalized + non-hospitalized patients","--","--","--",1,"COVIDAR anti-spike anti-RBD","n-227",252,289,87.2,82.79,90.82,"Yes","figure 1A",TRUE,"RBD, S","IgG IgM","ELISA","indirect",TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,36,250,148,283,83.0576241047269,86.4732523640513,51.6471513629201,97.5918688058638
"--","Europe","Scotland","{ ? }","hospitalized + non-hospitalized patients","*September 2020","*November 2020","--",4,"Abingdon AbC-19 IgG anti-spike","n-213",35,43,81.4,66.6,91.61,"Yes","table 3",TRUE,"S","IgG","LFIA","sandwich",FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,35,28,18,36,64.7375518164902,65.2058816826816,48.0868679207875,79.1707336309201
"--","Europe","Scotland","{ ? }","hospitalized + non-hospitalized patients","*September 2020","*November 2020","--",6,"Abingdon AbC-19 IgG anti-spike","n-213",50,73,68.49,56.56,78.87,"Yes","table 3",TRUE,"S","IgG","LFIA","sandwich",FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,35,34,13,55,46.1812457598251,45.9801828776981,20.3498415177295,73.5399122025624
"--","Europe","Scotland","{ ? }","hospitalized + non-hospitalized patients","*September 2020","*November 2020","--",2,"Abingdon AbC-19 IgG anti-spike","n-213",122,152,80.26,73.04,86.27,"Yes","table 3",TRUE,"S","IgG","LFIA","sandwich",FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,34,136,120,146,89.0969249774478,89.6434523576714,80.1769771874739,94.8316499019189
"1","Europe","Switzerland","{ Vaud }","convenience (general population)","5/4/2020","6/27/2020","5/31/2020",2.5,"SenASTrIS test (Sensitive Anti-SARS-CoV-2 Spike Trimer Immunoglobulin Serological)","n-301",215,219,98.17,95.39,99.5,"","table 1 (not yet included in seroreversion paper)",TRUE,"S","IgG IgA","ELISA","indirect",FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,33,193,111,216,84.414418708811,88.0004291433872,51.5433071890983,98.0164840710375
"1","Europe","Switzerland","11 cantons","representative","*October 2020","*February 2021","2020-12-20",1,"SenASTrIS test (Sensitive Anti-SARS-CoV-2 Spike Trimer Immunoglobulin Serological)","n-299",128,143,89.51,83.29,94.01,NA,"table 1 (not yet in seroreversion paper nor in PRISMA list / tab)",FALSE,"S","IgG IgA","ELISA","indirect",FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,32,136,102,143,92.6790839782434,95.0128561584874,72.4441711921525,99.3041566181938
"2","Europe","Spain","National","representative","5/18/2020","6/1/2020","2020-05-25",2,"Orient Gene Biotech COVID-19 IgG/IgM Rapid Test anti-spike","n-104",276,360,76.67,71.95,80.94,NA,"tabla 6 (page 19)",FALSE,"S","IgG IgM","LFIA","indirect",FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,31,304,158,352,80.7638759687284,84.4053140768024,44.5436218369548,97.4873808207952
"3","Europe","Spain","National","representative","6/8/2020","6/22/2020","2020-06-15",2,"Orient Gene Biotech COVID-19 IgG/IgM Rapid Test anti-spike","n-104",341,460,74.13,69.87,78.07,NA,"tabla 6 (page 19)",FALSE,"S","IgG IgM","LFIA","indirect",FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,31,388,199.975,449,80.582810852516,84.3751474472343,43.5420657485782,97.4047058530716
"4","Europe","Spain","National","representative","11/16/2020","11/29/2020","2020-11-22",2,"Orient Gene Biotech COVID-19 IgG/IgM Rapid Test anti-spike","n-45",1137,1777,63.98,61.7,66.22,NA,"tabla 8 (page 20)",FALSE,"S","IgG IgM","LFIA","indirect",FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,31,1502,778,1733,80.546232193759,84.5205549576849,43.6644585578719,97.5077295042322
"1","Europe","Spain","National","representative","4/27/2020","5/11/2020","2020-05-04",1,"Orient Gene Biotech COVID-19 IgG/IgM Rapid Test anti-spike","n-44",189,213,88.73,83.7,92.65,NA,"table 2",FALSE,"S","IgG IgM","LFIA","indirect",FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,30,173,89,207,77.9730511005848,81.3082317508037,42.2924186605165,96.4721970537333
"1","North America","USA","Hillsborough County, unvaccinated population","representative","*October 2020","*March 2021","",7,"New York, Mount Sinai RBD ELISA","n-178",25,26,96.15,80.36,99.9,"N","",TRUE,"RBD, S","IgG","ELISA","indirect",TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,29,25,22,26,96.3385769826332,96.8395774387299,90.6717789770786,99.1923435528641
"1","Europe","USA","Hillsborough County, unvaccinated population","representative","*October 2020","*March 2021","2021-01-01",4,"New York, Mount Sinai RBD ELISA","n-178",122,126,96.83,92.07,99.13,NA,"appendix table",FALSE,"RBD, S","IgG","ELISA","indirect",TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,28,119,104,125,93.8629356104234,94.731079204804,84.1911317802735,98.8012653181481
"--","Europe","Finland","{ 5 hospital districts }","convenience (general population)","--","--","*May 2021",13,"in-house THL Finland FMIA anti-spike assay","n-184",356,367,97,94.7,98.49,"Yes","5 districts listed in n-181 and are:  Uusimaa [contains Helsinki], Pirkanmaa, Pohjois-Pohjanmaa [a.k.a. North Ostrobothnia], Pohjois-Savo, Varsinais-Suomi",TRUE,"S","IgG","CMIA","indirect",FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,27,361,344,367,97.941994365981,98.3273075605862,94.0234939501071,99.6386758158116
"--","Europe","Finland","{ 5 hospital districts }","convenience (general population)","--","--","*October 2020",8,"in-house THL Finland FMIA anti-spike assay","n-184",360,367,98.09,96.11,99.23,"Yes","5 districts listed in n-181 and are:  Uusimaa [contains Helsinki], Pirkanmaa, Pohjois-Pohjanmaa [a.k.a. North Ostrobothnia], Pohjois-Savo, Varsinais-Suomi",TRUE,"S","IgG","CMIA","indirect",FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,26,354,336,363,96.0569871836676,96.3288500329422,92.1954173285209,98.4243550593556
"--","Oceania","New Zealand","{ Southern District Health Board region }","hospitalized + non-hospitalized patients","3/11/2020","4/5/2020","--",10,"Abbott Alinity SARS-CoV-2 IgG II Quant","n-198",36,37,97.3,85.84,99.93,"Yes","",TRUE,"RBD","IgG","CMIA","indirect",TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,25,33,7,37,79.4986041375667,88.0135998577747,19.5758102497333,99.5893306181294
"1","North America","USA","National (COVIDVu)","representative","--","--","2020-10-30",3,"BioRad Platelia Total Antibody nucleocapsid","n-143",77,127,60.63,51.57,69.18,NA,"",FALSE,"N","IgG IgM IgA","ELISA","sandwich",FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,24,116,65,127,87.0983422567402,91.3036865296693,52.0584635334186,99.069567410047
"2","North America","Canada","National (CCAHS), unvaccinated population","representative","11/2/2020","4/30/2021","2021-01-30",2,"CCAHS ELISA anti-spike anti-RBD anti-nucleocapsid (positive on at least 2 out of 3)","n-261",115,145,79.31,71.8,85.58,NA,"table 1",FALSE,"N, RBD, S","IgG","CMIA","indirect",TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,23,131,73,144,86.3742782026106,90.441354094664,51.9370796964288,98.9142531494457
"--","East Asia","South Korea","{ ? }","non-hospitalized patients","--","--","--",8,"EDI Novel coronavirus COVID19 IgG anti-nucleocapsid","n-165",15,58,25.86,15.26,39.04,"Yes","",TRUE,"N","IgG","ELISA","indirect",FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,22,25,1,55,45.2401520620413,43.0393591349658,3.48733462185568,94.2144309000017
"1","South Asia","India","West Bengal: Paschim Medinipur","representative","7/27/2020","8/7/2020","8/1/2020",2,"ERBALISA COVID-19 IgG","n-95",11,30,36.67,19.93,56.14,"Yes","",TRUE,"N, S","IgG","ELISA","indirect",FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,21,27,14,30,85.3498043485526,89.1332166139278,50.4492463357528,98.5496080937438
"3","South Asia","India","Delhi","representative","9/1/2020","9/7/2020","2020-09-04",2,"ERBALISA COVID-19 IgG","n-83",148,226,65.49,58.9,71.67,NA,"",FALSE,"N, S","IgG","ELISA","indirect",FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,21,202,112,224,85.3180509901953,89.4377836105888,49.8692228955718,98.6180796832218
"4","South Asia","India","Delhi","representative","10/15/2020","10/21/2020","2020-10-18",2,"ERBALISA COVID-19 IgG","n-83",147,260,56.54,50.28,62.65,NA,"",FALSE,"N, S","IgG","ELISA","indirect",FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,21,232,134,257,85.4812308174814,89.3071668661087,51.3424266018311,98.5786086307996
"--","Europe","Germany","{ Cologne }","hospitalized + non-hospitalized patients","*August 2020","*September 2020","--",5,"IDK (Immundiagnostik) anti-spike IgG","n-222",323,363,88.98,85.3,92.01,"Yes","supplementary table S2",TRUE,"S","IgG","ELISA","indirect",FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,20,310,115,359,79.7259046528216,85.4205193248066,32.2083876241023,98.6547460940279
"--","South Asia","India","{ Delhi }","hospitalized + non-hospitalized patients","--","--","12/18/2020",2,"in-house RBD ELISA (Mehdi et al.)","n-162",568,672,84.52,81.56,87.18,"N (excluded, non-commercial assay not used in a seroprevalence study)","",TRUE,"RBD","IgG","ELISA","indirect",TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,19,608,348,665,86.4915983685121,90.4583622063879,51.8594683301862,98.8597122037145
"--","East Asia","South Korea","{ ? }","non-hospitalized patients","--","--","--",8,"InBios SCoV-2 Detect IgG anti-spike ELISA","n-165",50,58,86.21,74.62,93.85,"Yes","",TRUE,"S","IgG","ELISA","indirect",FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,18,47,10,58,74.0206275914321,80.9955479097071,17.9802817850627,98.8897946056962
"2","South Asia","India","Delhi","representative","8/1/2020","8/7/2020","2020-08-04",1,"Kavach-AntiSARS-CoV-2 IgG ELISA (Zydus)","n-83",232,356,65.17,59.97,70.11,NA,"",FALSE,"N, RBD, S","IgG","ELISA","indirect",TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,17,322,190,353,86.7719365111329,90.4671428443489,53.7810773644226,98.7576513898436
"2","Europe","USA","Los Angeles County, unvaccinated population","representative","4/9/2021","4/25/2021","2021-04-17",4,"Luminex xMAP for spike and nucleocaspid (Los Angeles study used RBD portion)","n-174",57,59,97,90.3,99.1,NA,"table 2",FALSE,"RBD","IgG","CMIA","indirect",TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,16,53,26,59,85.2215097319831,89.9279641052388,45.8986790023934,98.9385758428898
"1","Europe","USA","Holyoke","representative","11/5/2020","12/31/2020","2020-12-03",2,"Massachusetts General Hospital, anti-spike ELISA","n-78",12,18,66.67,40.99,86.66,NA,"figure 2C",FALSE,"RBD","IgG","ELISA","indirect",TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,15,16,8,18,86.5930139006766,90.4747770004208,51.5298325399707,98.8778482408368
"--","North America","USA","{ ? }","non-hospitalized patients","--","--","--",3,"Siemens SARS-CoV-2 Total Advia Centaur","n-134",40,41,97.56,87.14,99.94,"Yes","",TRUE,"RBD","IgG IgM","CMIA","sandwich",TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,14,40,28,41,93.5565366977461,96.1417372286825,71.3740463765778,99.6007838429313
"1","Europe","Portugal","National (Castro et al.)","convenience (general population)","9/8/2020","10/14/2020","2020-09-26",3,"Siemens SARS-CoV-2 Total Advia Centaur","n-155",112,136,82.35,74.89,88.35,NA,"appendix 11",FALSE,"RBD","IgG IgM","CMIA","sandwich",TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,14,131,96,136,93.6039010725229,96.1768447555409,71.0526636063266,99.6207930963696
"--","North America","Canada","{ Toronto and Peel }","hospitalized + non-hospitalized patients","--","--","--",2.5,"Sinai Health (Toronto) anti-spike ELISA","n-169",22,22,100,84.56,100,"Yes","figure 3",TRUE,"S","IgG","CMIA","indirect",FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,13,19,9,22,83.5394812861434,87.9696976344622,43.5721328832376,98.4468499375392
"1","Latin America","Peru","Lima Metropolitana (provinces of Lima + Callao)","representative","6/28/2020","7/9/2020","2020-07-03",1,"Standard Q COVID-19 IgM/IgG Plus","k-15",77,84,91.67,83.58,96.58,NA,"table S9",FALSE,"N, RBD","IgG IgM","LFIA","indirect",TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,12,74,39,84,83.858817116215,88.0374219647233,47.1037093675524,98.5364765383605
"1","Middle East","Lebanon","National","representative","12/7/2020","1/15/2021","2020-12-26",2,"Techno Genetics anti-RBD, nCOVID-19 IgG/IgM POCT (point-of-care test)","n-150",38,60,63.33,49.9,75.41,NA,"table 3",FALSE,"RBD","IgG IgM","LFIA","indirect",TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,11,52,23,60,81.3962809117281,85.8171258954554,40.2440956579811,98.3347994764135
"--","East Asia","Japan","{ ? }","convenience (general population)","9/2/2020","10/26/2020","9/29/2020",6,"Tosoh anti-nucleocapsid IgG with AIA-CL1200","n-167",314,376,83.51,79.37,87.12,"Yes","",TRUE,"N","IgG","CMIA","indirect",FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,10,203,29,355,53.0438972747693,53.844523665747,7.93414109239578,94.1635125014038
"--","East Asia","Japan","{ ? }","convenience (general population)","9/2/2020","10/26/2020","9/29/2020",6,"Tosoh anti-nucleocapsid total Ig with AIA-CL1200","n-167",365,376,97.07,94.83,98.53,"Yes","",TRUE,"N","IgG IgM IgA etc.","CMIA","sandwich",FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,9,330,116,373,81.281686845764,87.9082621931544,30.9283009909851,99.1277724929645
"--","East Asia","Japan","{ ? }","convenience (general population)","9/2/2020","10/26/2020","9/29/2020",6,"Tosoh anti-spike IgG with AIA-CL1200","n-167",344,376,91.49,88.2,94.11,"Yes","",TRUE,"RBD","IgG","CMIA","indirect",TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,8,338,142,374,84.3861903796511,90.0257425251655,38.2049654590929,99.2609381606692
"--","East Asia","Japan","{ ? }","convenience (general population)","9/2/2020","10/26/2020","9/29/2020",6,"Tosoh anti-spike total Ig with AIA-CL1200","n-167",369,376,98.14,96.2,99.25,"Yes","",TRUE,"RBD","IgG IgM IgA etc.","CMIA","sandwich",TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,7,370,300,376,96.3579622710636,98.3498348539649,80.0847564736492,99.891670855588
"--","Europe","Germany","{ Cologne }","hospitalized + non-hospitalized patients","*August 2020","*September 2020","--",5,"Abbott Alinity i SARS-CoV-2 IgG nucleocapsid","n-222",195,363,53.72,48.44,58.94,"Yes","supplementary table S2",TRUE,"N","IgG","CMIA","indirect",FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,6,218,49,341,57.908515031915,59.9799493464695,13.7057069856947,93.6059959163256
"--","Europe","Ireland","{ Dublin }","hospitalized + non-hospitalized patients","3/26/2020","7/10/2020","5/18/2020",1,"Abbott Alinity i SARS-CoV-2 IgG nucleocapsid","n-225",149,185,80.54,74.09,85.98,"Yes","table 3",TRUE,"N","IgG","CMIA","indirect",FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,5,157,84,181,81.5319343023818,84.9949157552443,45.7989955053153,97.4197592188889
"--","North America","USA","{ Arkansas }","non-hospitalized patients","9/12/2020","10/24/2020","2020-10-03",2,"Beckman ACCESS SARS-CoV-2 anti-RBD","n-281",14,17,82.35,56.57,96.2,NA,"supplementary table 1 and table 1",FALSE,"RBD","IgG","CLIA","indirect",TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,4,15,10,17,85.570121039846,87.0857609417605,65.7390409521052,96.7834282839799
"--","North America","USA","{ Arkansas }","non-hospitalized patients","11/7/2020","12/19/2020","2020-11-28",2,"Beckman ACCESS SARS-CoV-2 anti-RBD","n-281",4,8,50,15.7,84.3,NA,"supplementary table 1 and table 1",FALSE,"RBD","IgG","CLIA","indirect",TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,4,7,4,8,85.570121039846,87.0857609417605,65.7390409521052,96.7834282839799
"--","North America","USA","{ Arkansas }","non-hospitalized patients","8/15/2020","9/5/2020","2020-08-25",1,"Beckman ACCESS SARS-CoV-2 anti-RBD","n-281",10,12,83.33,51.59,97.91,NA,"supplementary table 1 and table 1",FALSE,"RBD","IgG","CLIA","indirect",TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,3,9,5,12,75.9699135426555,76.5619038836472,58.9893405787579,89.1221701345135
"--","Europe","Scotland","{ ? }","hospitalized + non-hospitalized patients","*September 2020","*November 2020","--",2,"Biozek COVID-19 IgG/IgM rapid test","n-213",47,49,95.92,86.02,99.5,"Yes","table 2",TRUE,"N, RBD","IgG IgM","LFIA","indirect",TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,2,46,40,49,92.9457322599861,93.5289535162183,84.9159996952282,97.8219909394082
"--","Europe","Scotland","{ ? }","hospitalized + non-hospitalized patients","*September 2020","*November 2020","--",1,"Biozek COVID-19 IgG/IgM rapid test","n-213",65,68,95.59,87.64,99.08,"Yes","table 2",TRUE,"N, RBD","IgG IgM","LFIA","indirect",TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,1,65,59,68,95.0214637515553,95.4749590742435,88.879633566764,98.6129405995523
